BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID of Ligand PubChem SID of Ligand ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence PDB ID(s) of Target Chain UniProt (SwissProt) Recommended Name of Target Chain UniProt (SwissProt) Entry Name of Target Chain UniProt (SwissProt) Primary ID of Target Chain UniProt (SwissProt) Secondary ID(s) of Target Chain UniProt (SwissProt) Alternative ID(s) of Target Chain UniProt (TrEMBL) Submitted Name of Target Chain UniProt (TrEMBL) Entry Name of Target Chain UniProt (TrEMBL) Primary ID of Target Chain UniProt (TrEMBL) Secondary ID(s) of Target Chain UniProt (TrEMBL) Alternative ID(s) of Target Chain 681871 CC(C)(OCc1cc(-c2ccccc2)n(Cc2cccc(Cl)c2)n1)C(O)=O InChI=1S/C21H21ClN2O3/c1-21(2,20(25)26)27-14-18-12-19(16-8-4-3-5-9-16)24(23-18)13-15-7-6-10-17(22)11-15/h3-12H,13-14H2,1-2H3,(H,25,26) WRHIJCMSABCMKG-UHFFFAOYSA-N 345255 US10202350, Example 1 Malignant T-cell-amplified sequence 1 50000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345255&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124576 385451318 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681874 CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccc(Cl)cc2)n1)C(O)=O InChI=1S/C21H20Cl2N2O3/c1-21(2,20(26)27)28-13-18-11-19(15-5-9-17(23)10-6-15)25(24-18)12-14-3-7-16(22)8-4-14/h3-11H,12-13H2,1-2H3,(H,26,27) CRCDAXQBKNUOJO-UHFFFAOYSA-N 345256 2-[[5-(4-Chlorophenyl)-1-[(4- chlorophenyl)methyl[pyrazol-3- yl]methoxy]-2-methyl-propanoic acid 1H NMR (CD3OD, 400 MHz) $#948; 1.52 (s, 6H), 4.54 (s, 2H0, 5.329s, 2H), 6.48 (s, 1H), 6.91-7.00 (m, 1H), 7.21-7.30-(m, 2H), 7.31-7.38 (m, 2H), 7.40-7.48 (m 3H).::US10202350, Example 2::US10214492, Example 2::US11292767, Example 2 Malignant T-cell-amplified sequence 1 29000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345256&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129067 385451319 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681877 CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C21H20Cl2N2O3/c1-21(2,20(26)27)28-13-17-11-19(14-7-9-16(22)10-8-14)25(24-17)12-15-5-3-4-6-18(15)23/h3-11H,12-13H2,1-2H3,(H,26,27) HMGBBPKGJHXSQG-UHFFFAOYSA-N 345257 2-[[5-(4-Chlorophenyl)-1-[(2- chlorophenyl)methyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid 1H NMR (CD3OD, 400 MHz) $#948; 1.50 (s, 6H), 4.58 (s, 2H), 5.41 (s, 2H), 6.56 (s, 1H), 6.72-6.80 (m, 1H), 7.20-7.34 (m, 2H), 7.34-50 (m, 5H).::US10202350, Example 3::US10214492, Example 20::US11292767, Example 3 Malignant T-cell-amplified sequence 1 25000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345257&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129052 385451320 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681880 CC(C)(OCc1cc(-c2ccc(F)cc2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C21H20ClFN2O3/c1-21(2,20(26)27)28-13-17-11-19(14-7-9-16(23)10-8-14)25(24-17)12-15-5-3-4-6-18(15)22/h3-11H,12-13H2,1-2H3,(H,26,27) XKMFDWCMXXPXEC-UHFFFAOYSA-N 345258 2-[[1-[(2-Chlorophenyl)methyl]-5-(4- fluorophenyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid 1H NMR (CD3OD, 400 MHz) $#948; 1.51 (s, 6H), 4.58 (s, 2H), 5.40 (s, 2H), 6.55 (s, 1H), 6.70-6.78 (m, 1H), 7.14-7.18 (m, 2H), 7-20- 7.29 (m, 2H), 7.32-7.40 (m, 3H).::US10202350, Example 4::US10214492, Example 4::US11292767, Example 4 Malignant T-cell-amplified sequence 1 33000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345258&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129046 385451321 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681883 CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccc(Cl)cc2Cl)n1)C(O)=O InChI=1S/C21H19Cl3N2O3/c1-21(2,20(27)28)29-12-17-10-19(13-3-6-15(22)7-4-13)26(25-17)11-14-5-8-16(23)9-18(14)24/h3-10H,11-12H2,1-2H3,(H,27,28) RZGBMPZXWLXWJO-UHFFFAOYSA-N 345259 2-[[5-(4-Chlorophenyl)-1-[(2,4- dichlorophenyl)methyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid 1H NMR (CD3OD, 400 MHz) $#948; 1.48 (s, 6H), 4.58 (s, 2H), 5.40 (s, 2H), 6.54 (s, 1H), 6.73 (d, 1H), 7.20-7.38 (m, 3H), 7.40-48 (m, 3H).::US10202350, Example 5::US10214492, Example 5::US11292767, Example 5 Malignant T-cell-amplified sequence 1 400 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345259&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129068 385451322 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681886 OC(=O)COCc1cc(-c2ccc(Cl)cc2)n(Cc2ccc(Cl)cc2Cl)n1 InChI=1S/C19H15Cl3N2O3/c20-14-4-1-12(2-5-14)18-8-16(10-27-11-19(25)26)23-24(18)9-13-3-6-15(21)7-17(13)22/h1-8H,9-11H2,(H,25,26) BEHYBUQUZGAMAX-UHFFFAOYSA-N 345260 2-[[5-(4-Chlorophenyl)-1-[(2,4- dichlorophenyl)methyl]pyrazol-3- yl]methoxy]acetic acid 1H NMR (DMSO-d6, 400 MHz) $#948; 3.80 (s, 2H), 4.50 9s, 2H), 5.30 (s, 2H), 6.50 (s, 1H), 6.60-80 (m, 1H), 7.20-70 (m, 6H).::US10202350, Example 6::US10214492, Example 6::US11292767, Example 6 Malignant T-cell-amplified sequence 1 303 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345260&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129042 385451323 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681889 CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccccc2)n1)C(O)=O InChI=1S/C21H21ClN2O3/c1-21(2,20(25)26)27-14-18-12-19(16-8-10-17(22)11-9-16)24(23-18)13-15-6-4-3-5-7-15/h3-12H,13-14H2,1-2H3,(H,25,26) YQVHVXDTVAZPQY-UHFFFAOYSA-N 345261 2-[[1-Benzyl-5-(4-Chlorophenyl)pyrazol- 3-yl]methoxy]-2-methyl-propanoic acid 1H NMR (CD3OD, 400 MHz) $#948; 1.53 (s, 6H), 4.58 (s, 2H), 5.38 (s, 2H), 6.51 (s, 1H), 6.90 (d, 2H), 7.18-7.50 (m, 7H).::US10202350, Example 7::US10214492, Example 7::US11292767, Example 7 Malignant T-cell-amplified sequence 1 70000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345261&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129040 385451324 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681892 CC(C)(OCc1cc(-c2ccccc2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C21H21ClN2O3/c1-21(2,20(25)26)27-14-17-12-19(15-8-4-3-5-9-15)24(23-17)13-16-10-6-7-11-18(16)22/h3-12H,13-14H2,1-2H3,(H,25,26) VJWGGMIQMWUNTA-UHFFFAOYSA-N 345262 2-[[1-[(2-Chlorophenyl)methyl]-5-phenyl- pyrazol-3-yl]methoxy]-2-methyl- propanoic acid 1H NMR (DMSO-d6, 400 MHz) $#948; 1.56 (s, 6H), 4.58 (s, 2H), 5.41 (s, 2H), 6.56 (s, 1H), 6.75-6.78 (m, 1H), 7.20-7.30 (m, 4H), 7.32-7.43 (m, 4H). 1H NMR (CD3OD, 400 MHz) $#948; 1.54 (s, 6H), 4.589s, 2H), 5.40 (s, 2H), 6.55 (s, 1H), 6.68-6.74 (m, 1H), 7.20-7.42 (m, 8H).::US10202350, Example 8::US10214492, Example 8::US11292767, Example 8 Malignant T-cell-amplified sequence 1 46000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345262&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129038 385451325 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681895 CC(C)(OCc1cc(-c2ccccc2Cl)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C21H20Cl2N2O3/c1-21(2,20(26)27)28-13-15-11-19(16-8-4-6-10-18(16)23)25(24-15)12-14-7-3-5-9-17(14)22/h3-11H,12-13H2,1-2H3,(H,26,27) WJTWNXAITZFXSZ-UHFFFAOYSA-N 345263 2-[[5-(2-Chlorophenyl)-1-[(2- chlorophenyl)methyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid 1H NMR (CD3OD, 400 MHz) $#948; 1.53 (s, 6H), 4.58 (s, 2H), 5.28 (s, 2H), 6.43 (s, 1H), 6.78-7.81 (m, 1H), 7.16-34 (m, 5H), 7.38- 7.42 (m, 1H), 7.50-7.56 (m, 1H).::US10202350, Example 9::US10214492, Example 9::US11292767, Example 9 Malignant T-cell-amplified sequence 1 39000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345263&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129062 385451326 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681898 CC(C)(OCc1cc(-c2cccc(Cl)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C21H20Cl2N2O3/c1-21(2,20(26)27)28-13-17-11-19(14-7-5-8-16(22)10-14)25(24-17)12-15-6-3-4-9-18(15)23/h3-11H,12-13H2,1-2H3,(H,26,27) SGFRVEMOPYHHFG-UHFFFAOYSA-N 345264 2-[[5-(3-Chlorophenyl)-1-[(2- chlorophenyl)methyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid 1H NMR (CD3OD, 400 MHz) $#948; 1.32 (S, 6h) 4.58 (s, 2H), 5.42 (s, 2H), 6.57 (s, 1H), 6.67-6.80 (m, 1H), 7.22-7.30 (m, 3H), 7.32-42 (m, 4H).::US10202350, Example 10::US10214492, Example 10::US11292767, Example 10 Malignant T-cell-amplified sequence 1 404 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345264&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129043 385451327 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681901 Cc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C22H23ClN2O3/c1-15-7-6-9-16(11-15)20-12-18(14-28-22(2,3)21(26)27)24-25(20)13-17-8-4-5-10-19(17)23/h4-12H,13-14H2,1-3H3,(H,26,27) GKQYGOVLFGQJQP-UHFFFAOYSA-N 345265 2-[[1-[(2-Chlorophenyl)methyl]-5-(m- tolyl)pyrazol-3-yl]methoxy]-2-methyl- propanoic acid 1H NMR (CDCl3, 400 MHz) $#948; 1.58 (s, 6H), 2.35 (s, 3H), 4.61 (s, 2H), 5.42 (s, 2H), 6.39 (s, 1H), 6.75-6.84 (m, 1H), 7.00- 7.12 (m, 2H), 7.18-7.29 (4H), 7.29-7.38 (m, 1H).::US10202350, Example 11::US10214492, Example 11::US11292767, Example 11 Malignant T-cell-amplified sequence 1 29000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345265&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129047 385451328 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681904 CC(C)(OCc1cc(-c2cccc(F)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C21H20ClFN2O3/c1-21(2,20(26)27)28-13-17-11-19(14-7-5-8-16(23)10-14)25(24-17)12-15-6-3-4-9-18(15)22/h3-11H,12-13H2,1-2H3,(H,26,27) DSCSGSGYDAITAF-UHFFFAOYSA-N 345266 2-[[1-[(2-Chlorophenyl)methyl]-5-(3- fluorophenyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid 1H NMR (CDCl3, 400 MHz) $#948; 1.58 (s, 6H), 4.64 (s, 2H), 5.48 (s, 2H), 6.42 (s, 1H), 6.72-6.85 (m, 1H), 6.88-7.14 (m, 3H), 7.14-7.40 (m, 4H).::US10202350, Example 12::US10214492, Example 12::US11292767, Example 12 Malignant T-cell-amplified sequence 1 58000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345266&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129070 385451329 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681907 CC(C)(OCc1cc(-c2cccc(c2)C(F)(F)F)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C22H20ClF3N2O3/c1-21(2,20(29)30)31-13-17-11-19(14-7-5-8-16(10-14)22(24,25)26)28(27-17)12-15-6-3-4-9-18(15)23/h3-11H,12-13H2,1-2H3,(H,29,30) MOTLXMCQEMVWNK-UHFFFAOYSA-N 345267 2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (trifluoromethyl)phenyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid 1H NMR (CDCl3, 400 MHz) $#948; 1.58 (s, 6H), 4.62 (s, 2H), 5.41 (s, 2H), 6.46 (s, 1H), 6.80-6.88 (m, 1H), 7.17-7.24 (m, 2H), 7.29-7.38 (m, 1H), 7.39-7.47 (m, 1H), 7.49-7.54 (m, 2H), 7.59-7.68 (m, 1H).::US10202350, Example 13::US10214492, Example 13::US11292767, Example 13 Malignant T-cell-amplified sequence 1 17000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345267&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129049 385451330 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681910 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C22H23ClN2O4/c1-22(2,21(26)27)29-14-17-12-20(15-8-6-9-18(11-15)28-3)25(24-17)13-16-7-4-5-10-19(16)23/h4-12H,13-14H2,1-3H3,(H,26,27) XWCDPGKAMJDMKE-UHFFFAOYSA-N 345268 2-[[1-[(2-Chlorophenyl)methyl]-5-(3- methoxyphenyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid 1H NMR (CDCl3, 400 MHz) $#948; 1.58 (s, 6H), 3.68 (s, 3H), 4.62 (s, 2H), 5.46 (s, 2H), 6.42 (s, 1H), 6.74-6.81 (m, 2H), 6.82- 6.88 (m, 1H), 6.89-6.94 (m, 1H), 7.15- 7023 (m, 2H), 7.26-7.37 (m, 2H).::US10202350, Example 14::US10214492, Example 14::US11292767, Example 14 Malignant T-cell-amplified sequence 1 100000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345268&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124649 385451331 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681913 CC(C)(OCc1cc(C2CCCCC2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C21H27ClN2O3/c1-21(2,20(25)26)27-14-17-12-19(15-8-4-3-5-9-15)24(23-17)13-16-10-6-7-11-18(16)22/h6-7,10-12,15H,3-5,8-9,13-14H2,1-2H3,(H,25,26) PQDUNIFUBNVPSK-UHFFFAOYSA-N 345269 2-[[1-[(2-Chlorophenyl)methyl]-5- cyclohexyl-pyrazol-3-yl]methoxy]-2- methyl-propanoic acid 1H NMR (CDCl3, 400 MHz) $#948; 1.16-1.42 (m, 4H), 1.54 (s, 6H), 1.57-1.81 (m, 5H), 2.36-2051 (m, 1H), 2.76-2.91 (m, 1H), 4.56 (s, 2H), 5.39 (s, 2H), 6.15 (s, 1H), 6.54-6.68 (m, 1H), 7.08-7.25 (m, 2H), 7.31-7.44 (m, 1H).::US10202350, Example 15::US10214492, Example 15::US11292767, Example 15 Malignant T-cell-amplified sequence 1 33000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345269&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129051 385451332 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681916 CC(C)(OCc1cc(C2CCCC2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C20H25ClN2O3/c1-20(2,19(24)25)26-13-16-11-18(14-7-3-4-8-14)23(22-16)12-15-9-5-6-10-17(15)21/h5-6,9-11,14H,3-4,7-8,12-13H2,1-2H3,(H,24,25) XMKOXEBLOHACSC-UHFFFAOYSA-N 345270 2-[[1-[(2-Chlorophenyl)methyl]-5- cyclopentyl-pyrazol-3-yl]methoxy]-2- methyl-propanoic acid 1H NMR (CDCl3, 400 MHz) $#948; 1.22- 1.64 (m, 10H), 1.64-1.80 (m, 2H), 1.82- 2.00 (m, 2H), 2.80-2.92 (m, 1H), 4.74 (s, 2H), 5.40 (s, 2H), 6.10 (s, 1H), 6.58-6.62 (m, 1H), 7.10-7.22 (m, 2H), 7.38 (d, 1H).::US10202350, Example 16::US10214492, Example 16::US11292767, Example 16 Malignant T-cell-amplified sequence 1 73000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345270&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124125966 385451333 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681919 OC(=O)C1(CC1)OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccccc2Cl)n1 InChI=1S/C21H18Cl2N2O3/c22-16-7-5-14(6-8-16)19-11-17(13-28-21(9-10-21)20(26)27)24-25(19)12-15-3-1-2-4-18(15)23/h1-8,11H,9-10,12-13H2,(H,26,27) PPYZGAFFTAKWEP-UHFFFAOYSA-N 345271 1-[[5-(4-Chlorophenyl)-1-[(2- chlorophenyl)methyl]pyrazol-3- yl]methoxy]cyclopropanecarboxylic acid 1H NMR (CD3OD, 400 MHz) $#948; 1.18- 1.32 (m, 3H), 1.64-1.80 (m, 1H), 4.61 (s, 2H), 5.42 (s, 2H), 6.52 (s, 1H), 6.60-6.80 (m, 1H), 7.20-52 (m, 7H).::US10202350, Example 17::US10214492, Example 17::US11292767, Example 17 Malignant T-cell-amplified sequence 1 100 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345271&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129063 385451334 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681922 CC(C)(OCc1cc(-c2nccs2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C18H18ClN3O3S/c1-18(2,17(23)24)25-11-13-9-15(16-20-7-8-26-16)22(21-13)10-12-5-3-4-6-14(12)19/h3-9H,10-11H2,1-2H3,(H,23,24) TVGXZDZQUAYVPW-UHFFFAOYSA-N 345272 2-[[1-[(2-Chlorophenyl)methyl]-5-thiazol- 2-yl-pyrazol-3-yl]methoxy]-2-methyl- propanoic acid 1H NMR (CDCl3, 400 MHz) $#948; 1.38 (m, 6H), 4.48 (s, 2H), 5.61 (s, 2H), 6.55-6.65 (m, 1H), 7.03 (s, 1H), 7.09-7.16 (m, 1H), 7.17-7.23 (m, 1H), 7.27-7.33 (d, 1H), 7.34- 7.42 (m, 1H), 7.88-7.96 (d, 1H).::US10202350, Example 18::US10214492, Example 18::US11292767, Example 18 Malignant T-cell-amplified sequence 1 45000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345272&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124125968 385451335 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681925 CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccccc2F)n1)C(O)=O InChI=1S/C21H20ClFN2O3/c1-21(2,20(26)27)28-13-17-11-19(14-7-9-16(22)10-8-14)25(24-17)12-15-5-3-4-6-18(15)23/h3-11H,12-13H2,1-2H3,(H,26,27) GSNVCGIVPFJNNK-UHFFFAOYSA-N 345273 2-[[5-(4-Chlorophenyl)-1-[(2- fluorophenyl)methyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid 1H NMR (CD3OD, 400 MHz) $#948; 1.48 (s, 6H), 4.53 (s, 2H) 5.38 (s, 2H), 6.50 (s, 1H), 6.81-6.92 (m 1H), 7.00-7.13 (m, 2H), 7.21- 7.31 (m 1H), 7.34-7.48 (m 4H)::US10202350, Example 19::US10214492, Example 19::US11292767, Example 19 Malignant T-cell-amplified sequence 1 57000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345273&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129054 385451336 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681928 CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccccc2Cl)n1)C(N)=O InChI=1S/C21H21Cl2N3O2/c1-21(2,20(24)27)28-13-17-11-19(14-7-9-16(22)10-8-14)26(25-17)12-15-5-3-4-6-18(15)23/h3-11H,12-13H2,1-2H3,(H2,24,27) IBNAYOBYCPXGCL-UHFFFAOYSA-N 345274 2-[[5-(4-Chlorophenyl)-1-[(2- chlorophenyl)methyl]pyrazol-3- yl]methoxy]-2-methyl-propanamide 1H NMR (CD3OD 400 MHz) $#948; 1.46 (s, 6H), 4.58 (s, 2H), 5.40 (s, 2H), 6.52 (s, 1H), 6.71-6.76 (m, 1H), 7.20-7.58 (m, 6H)::US10202350, Example 20::US11292767, Example 20 Malignant T-cell-amplified sequence 1 454 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345274&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129065 385451337 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681931 CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccncc2)n1)C(O)=O InChI=1S/C20H20ClN3O3/c1-20(2,19(25)26)27-13-17-11-18(15-3-5-16(21)6-4-15)24(23-17)12-14-7-9-22-10-8-14/h3-11H,12-13H2,1-2H3,(H,25,26) CROGBSNJYJQYMJ-UHFFFAOYSA-N 345275 2-[[5-(4-chlorophenyl)-1-(4- pyridylmethyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid 1H NMR (CD3OD 400 MHz) $#948; 1.52 (s, 6H), 4.58 (s, 2H), 5.56 (s, 2H), 6.59 (s, 1H), 7.21-7.52 (m, 6H), 8.50 (bs, 2H)::US10202350, Example 21::US10214492, Example 21::US11292767, Example 21 Malignant T-cell-amplified sequence 1 300000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345275&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129055 385451338 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681934 CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccccn2)n1)C(O)=O InChI=1S/C20H20ClN3O3/c1-20(2,19(25)26)27-13-17-11-18(14-6-8-15(21)9-7-14)24(23-17)12-16-5-3-4-10-22-16/h3-11H,12-13H2,1-2H3,(H,25,26) DAANKWPDRAFQBB-UHFFFAOYSA-N 345276 2-[[5-(4-Chlorophenyl)-1-(2- pyridylmethyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid 1H NMR (DMSO-d6, 400 MHz) $#948; 1.38 (s, 6H), 4.40 (s, 2H), 5.38 (s, 2H), 6.41 (s, 1H), 6.90-7.10 (m, 1H), 7.20-7.85 (m, 6H), 8.51 (bs, 1H)::US10202350, Example 22::US10214492, Example 22::US11292767, Example 22 Malignant T-cell-amplified sequence 1 150000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345276&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129060 385451339 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681937 CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2cccnc2)n1)C(O)=O InChI=1S/C20H20ClN3O3/c1-20(2,19(25)26)27-13-17-10-18(15-5-7-16(21)8-6-15)24(23-17)12-14-4-3-9-22-11-14/h3-11H,12-13H2,1-2H3,(H,25,26) RIHUQGLIJOYTGB-UHFFFAOYSA-N 345277 2-[[5-(4-Chlorophenyl)-1-(3- pyridylmethyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid 1H NMR (CD3OD 400 MHz) $#948; 1.52 (s, 6H), 4.58 (s, 2H), 5.10 (s, 2H), 6.55 (s, 1H), 7.30-7.41 (m, 3H), 7.42-7.51 (m, 3H), 8.19 (s, 1H), 8.41 (d, 1H).::US10202350, Example 23::US10214492, Example 23::US11292767, Example 23 Malignant T-cell-amplified sequence 1 300000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345277&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129061 385451340 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681939 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C22H23ClN2O4/c1-22(2,21(26)27)29-14-17-12-20(15-8-6-9-18(11-15)28-3)25(24-17)13-16-7-4-5-10-19(16)23/h4-12H,13-14H2,1-3H3,(H,26,27) XWCDPGKAMJDMKE-UHFFFAOYSA-N 345268 2-[[1-[(2-Chlorophenyl)methyl]-5-(3- methoxyphenyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid 1H NMR (CDCl3, 400 MHz) $#948; 1.58 (s, 6H), 3.68 (s, 3H), 4.62 (s, 2H), 5.46 (s, 2H), 6.42 (s, 1H), 6.74-6.81 (m, 2H), 6.82- 6.88 (m, 1H), 6.89-6.94 (m, 1H), 7.15- 7023 (m, 2H), 7.26-7.37 (m, 2H).::US10202350, Example 14::US10214492, Example 14::US11292767, Example 14 Malignant T-cell-amplified sequence 1 100000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345268&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124649 385451331 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681941 CC(C)(OCc1cc(-c2ccsc2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C19H19ClN2O3S/c1-19(2,18(23)24)25-11-15-9-17(14-7-8-26-12-14)22(21-15)10-13-5-3-4-6-16(13)20/h3-9,12H,10-11H2,1-2H3,(H,23,24) HKHYLTKVTHHUQC-UHFFFAOYSA-N 345278 2-[[1-[(2-Chlorophenyl)methyl]-5-(3- thienyl)pyrazol-3-yl]methoxy]-2-methyl- propanoic acid. 1HNMR (CDCl3): $#948; 1.37 (s, 6H), 4.38 (s, 2H), 5.43 (s, 2H), 6.48 (s, 1H), 6.62-6.64 (m, 1H), 7.17-7.31 (m, 3H), 7.44-7.46 (m, 1H), 7.57-7.64 (m, 2H).::US10202350, Example 24::US10214492, Example 24::US11292767, Example 24 Malignant T-cell-amplified sequence 1 100000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345278&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124604 385451341 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681943 CC(C)(OCc1cc(-c2cccs2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C19H19ClN2O3S/c1-19(2,18(23)24)25-12-14-10-16(17-8-5-9-26-17)22(21-14)11-13-6-3-4-7-15(13)20/h3-10H,11-12H2,1-2H3,(H,23,24) ANFLHRJGCPODLC-UHFFFAOYSA-N 345279 2-[[1-[(2-Chlorophenyl)methyl]-5-(2- thienyl)pyrazol-3-yl]methoxy]-2-methyl- propanoic acid. 1HNMR (CDCl3): $#948; 1.37 (s, 6H), 4.39 (s, 2H), 5.47 (s, 2H), 6.53 (s, 1H), 6.59-6.61 (m, 1H), 7.09-7.14 (m, 2H), 7.24-7.31 (m, 2H), 7.45-7.47 (m, 1H), 7.62-7.64 (m, 1H).::US10202350, Example 25::US10214492, Example 25::US11292767, Example 25 Malignant T-cell-amplified sequence 1 77000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345279&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124526 385451342 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681945 CC(C)COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1F InChI=1S/C25H29FN2O4/c1-17(2)15-31-21-10-7-9-18(12-21)23-13-20(16-32-25(3,4)24(29)30)27-28(23)14-19-8-5-6-11-22(19)26/h5-13,17H,14-16H2,1-4H3,(H,29,30) BHQQWIODAIFPLX-UHFFFAOYSA-N 345280 2-[[1-[(2-Fluorophenyl)methyl]-5-(3- isobutoxyphenyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid 1HNMR (CDCl3): $#948; 0.97 (s, 3H), 0.99 (s, 3H), 1.55 (s, 6H), 2.00-2.06 (m, 1H), 3.70 (d, 2H), 4.62 (s, 2H), 5.39 (s, 2H), 6.37 (s, 1H), 6.79-6.80 (m, 1H), 6.87-7.09 (M, 5H), 7.22-7.30 (m, 2H)::US10202350, Example 26::US10214492, Example 26::US11292767, Example 26 Malignant T-cell-amplified sequence 1 27000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345280&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129069 385451343 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681947 CC(C)COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C25H29ClN2O4/c1-17(2)15-31-21-10-7-9-18(12-21)23-13-20(16-32-25(3,4)24(29)30)27-28(23)14-19-8-5-6-11-22(19)26/h5-13,17H,14-16H2,1-4H3,(H,29,30) RUFWXTRLNGUAJT-UHFFFAOYSA-N 345281 2-[[1-[(2-Chlorophenyl)methyl]-5-(3- isobutoxyphenyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid. 1HNMR (CDCl3): $#948; 0.95 (s, 3H)(, 0.96 (s, 3H), 1.56 (s, 6H), 1.97-2.03 (m, 1H), 3.49 (d, 2H), 4.63 (s, 2H), 5.43 (s, 2H), 6.41 (s, 1H), 6.73-6.80 (m, 2H), 6.84- 6.92 (m, 2H), 7.19-7.28 (m, 3H), 7.33- 7.35 (m, 1H).::US10202350, Example 27::US10214492, Example 27::US11292767, Example 27 Malignant T-cell-amplified sequence 1 302 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345281&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124776 385451344 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681949 CCOc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C23H25ClN2O4/c1-4-29-19-10-7-9-16(12-19)21-13-18(15-30-23(2,3)22(27)28)25-26(21)14-17-8-5-6-11-20(17)24/h5-13H,4,14-15H2,1-3H3,(H,27,28) XSADINSCPLDDCJ-UHFFFAOYSA-N 345282 2-[[1-[(2-Chlorophenyl)methyl]-5-(3- ethoxyphenyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.34 (t, 3H),, 1.56 (s, 6H), 3.86 (q, 2H), 4.62 (s, 2H), 5.43 (s, 2H), 6.40 (s, 1H), 6.76-6.78 (m, 2H), 6.83- 6.85 (m, 1H), 6.89-6.91 (m, 1H), 7.19-7.28 (m, 3H), 7.33-7.35 (m, 1H).::US10202350, Example 28::US10214492, Example 28::US11292767, Example 28 Malignant T-cell-amplified sequence 1 15000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345282&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124523 385451345 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681951 CC(C)Oc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Br InChI=1S/C24H27BrN2O4/c1-16(2)31-20-10-7-9-17(12-20)22-13-19(15-30-24(3,4)23(28)29)26-27(22)14-18-8-5-6-11-21(18)25/h5-13,16H,14-15H2,1-4H3,(H,28,29) YUSRRLUKSSUTRE-UHFFFAOYSA-N 345283 2-[[1-[(2-Bromophenyl)methyl]-5-(3- isopropoxyphenyl)pyrazol-3-yl]methoxy]- 2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.21 (s, 3H), 1.23 (s, 3H), 4.28-4.32 (m, 1H), 4.62 (s, 2H), 5.39 (s, 2H).6.42 (s, 1H), 6.71-6.74 (m, 2H), 6.82- 6.89 (m, 2H), 7.11-7.15 (m, 1H), 7.22- 7.27 (m, 2H), 7.51-7.54 (m, 1H).::US10202350, Example 29::US10214492, Example 29::US11292767, Example 29 Malignant T-cell-amplified sequence 1 16000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345283&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124543 385451346 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681953 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Br InChI=1S/C22H23BrN2O4/c1-22(2,21(26)27)29-14-17-12-20(15-8-6-9-18(11-15)28-3)25(24-17)13-16-7-4-5-10-19(16)23/h4-12H,13-14H2,1-3H3,(H,26,27) LUHYWMZESCMRFH-UHFFFAOYSA-N 345284 2-[[1-[(2-Bromophenyl)methyl]-5-(3- methoxyphenyl)-1H-pyrazol-3- yl]methoxy]-2-methylpropanoic acid 1HNMR (CDCl3): $#948; 1.56 (s, 6H), 3.65 (s, 3H), 4.62 (s, 2H), 5.39 (s, 2H), 6.41 (s, 1H), 6.73-6.76 (m 2H), 6.84-6.92 (m, 2H), 7.15 (t, 1H), 7.13-7.29 (m, 2H), 7.52- 7.54 (m, 1H).::US10202350, Example 30::US10214492, Example 30::US11292767, Example 30 Malignant T-cell-amplified sequence 1 27000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345284&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129064 385451347 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681955 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1C(C)C InChI=1S/C25H30N2O4/c1-17(2)22-12-7-6-9-19(22)15-27-23(18-10-8-11-21(13-18)30-5)14-20(26-27)16-31-25(3,4)24(28)29/h6-14,17H,15-16H2,1-5H3,(H,28,29) SWYAUQCCJYORQT-UHFFFAOYSA-N 345285 2-[[1-[(2-Isopropylphenyl)methyl]-5-(3- methoxyphenyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.13 (s, 3H), 1.15 (s, 3H), 1.55 (s 6H), 2.94-2.97 (m, 1H), 3.62 (s, 3H), 4.63 (s, 2H), 5.42 (s, 2H), 6.39 (s, 1H), 6.65-6.67 (m, 1H), 6.75-6.76 (m, 1H), 6.85-6.91 (m, 2H), 7.07-7.11 (m, 1H), 7.21-7.28 (m, 3H)::US10202350, Example 31::US10214492, Example 31::US11292767, Example 31 Malignant T-cell-amplified sequence 1 42000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345285&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124786 385451348 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681957 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1C InChI=1S/C23H26N2O4/c1-16-8-5-6-9-18(16)14-25-21(17-10-7-11-20(12-17)28-4)13-19(24-25)15-29-23(2,3)22(26)27/h5-13H,14-15H2,1-4H3,(H,26,27) RWLFLALIRUWRCB-UHFFFAOYSA-N 345286 2-[[5-(3-Methoxyphenyl)-1-(o- tolylmethyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.55 (s, 6H), 2.18 (s, 3H), 3.64 (s, 3H), 4.62 9s, 2H), 5.31 (s, 2H), 6.38 (s, 1H), 6.69-6.31 (m, 1H), 6.77- 6.78 (m, 1H), 6.86-6.92 (m, 2H), 7.10-7.15 (m, 3H), 7.25-7.29 (m, 1H).::US10202350, Example 32::US10214492, Example 32::US11292767, Example 32 Malignant T-cell-amplified sequence 1 83000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345286&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124771 385451349 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681959 CC(C)(OCc1cc(-c2cccc(OCC3CC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C25H27ClN2O4/c1-25(2,24(29)30)32-16-20-13-23(28(27-20)14-19-6-3-4-9-22(19)26)18-7-5-8-21(12-18)31-15-17-10-11-17/h3-9,12-13,17H,10-11,14-16H2,1-2H3,(H,29,30) JKSRDKKNSRKQBO-UHFFFAOYSA-N 345287 2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopropylmethoxy)phenyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 0.25-0.29 (m, 2H), 0.58-0.63 (m, 2H), 14.16-1.20 (m, 1H), 1.55 (s, 6H), 5.58 (d, 2H), 4.63 (s, 2H), 5.42 (s, 2H), 6.40 (s, 1H), 6.374-6.78 (m, 2H), 6.84-6.93 (m, 2H), 7.18-7.28 (m, 3H), 7.33-7.35 (m, 1H).::US10202350, Example 33::US10214492, Example 33::US11292767, Example 33 Malignant T-cell-amplified sequence 1 54.5 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345287&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124652 385451350 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681961 CC(C)(OCc1cc(-c2cccc(OC(F)(F)F)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C22H20ClF3N2O4/c1-21(2,20(29)30)31-13-16-11-19(14-7-5-8-17(10-14)32-22(24,25)26)28(27-16)12-15-6-3-4-9-18(15)23/h3-11H,12-13H2,1-2H3,(H,29,30) BESJCDJSBOQPDC-UHFFFAOYSA-N 345288 2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (trifluoromethoxy)phenyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.56 (6H), 4.63 (s, 2H), 5.41 (s, 2H), 6.46 (s, 1H), 6.77-6.79 (m, 1H), 7.12-7.25 (m, 5H), 7.32-7.35 (m, 1H), 7.38- 7.42 (m, 1H).::US10202350, Example 34::US10214492, Example 34::US11292767, Example 34 Malignant T-cell-amplified sequence 1 11000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345288&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124522 385451351 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681963 CC(C)Oc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C24H27ClN2O4/c1-16(2)31-20-10-7-9-17(12-20)22-13-19(15-30-24(3,4)23(28)29)26-27(22)14-18-8-5-6-11-21(18)25/h5-13,16H,14-15H2,1-4H3,(H,28,29) IGDIAXPECYMBDX-UHFFFAOYSA-N 345289 2-[[1-[(2-Chlorophenyl)methyl]-5-(3- isopropoxyphenyl)pyrazol-3-yl]methoxy]- 2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.22 (s, 3H)(, 1.23 (s, 3H), 1.55 (s, 6H), 4.30-4.33 (m, 1H), 4.62 (s, 2H), 5.43 (s, 2H), 6.41 (s, 1H), 6.75- 6.90 (4H), 7.19-7.35 (m, 4H).::US10202350, Example 35::US10214492, Example 35::US11292767, Example 35 Malignant T-cell-amplified sequence 1 59000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345289&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124544 385451352 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681965 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1OC InChI=1S/C23H26N2O5/c1-23(2,22(26)27)30-15-18-13-20(16-9-7-10-19(12-16)28-3)25(24-18)14-17-8-5-6-11-21(17)29-4/h5-13H,14-15H2,1-4H3,(H,26,27) IKHJKMPPVIIEAP-UHFFFAOYSA-N 345290 2-[[5-(3-Methoxyphenyl)-1-[(2- methoxyphenyl)methyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.55 (s. 6H), 3.70 (s, 3H), 3.73 (s, 3H), 4.62 (s, 2H), 5.34 (s, 2H), 6.35 (s, 1H), 6.77-6.392 (m, 6H), 7.22- 7.29 (m, 2H).::US10202350, Example 36::US10214492, Example 36::US11292767, Example 36 Malignant T-cell-amplified sequence 1 50000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345290&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124537 385451353 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681967 CC(C)(OCc1cc(-c2cccc(OC3CCC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C25H27ClN2O4/c1-25(2,24(29)30)31-16-19-14-23(28(27-19)15-18-7-3-4-12-22(18)26)17-8-5-11-21(13-17)32-20-9-6-10-20/h3-5,7-8,11-14,20H,6,9-10,15-16H2,1-2H3,(H,29,30) YWAWTBJHCYHBMP-UHFFFAOYSA-N 345291 2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclobutoxy)phenyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.49-1.61 (m, 7H), m1.75-1.82 (m 1H), 2.01-2.11 (m 2H), 2.17-2.24 (m 2H), 4.37-4.45 (m 1H), 4.62 (s, 2H), 5.42 (s, 2H), 6.39 (s, 1H), 6.64 (s, 1H), 6.75-6.86 (m, 3H), 7.19-7.35 (m 4H).::US10202350, Example 37::US10214492, Example 37::US11292767, Example 37 Malignant T-cell-amplified sequence 1 204 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345291&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124577 385451354 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681969 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1N(C)C InChI=1S/C24H29N3O4/c1-24(2,23(28)29)31-16-19-14-22(17-10-8-11-20(13-17)30-5)27(25-19)15-18-9-6-7-12-21(18)26(3)4/h6-14H,15-16H2,1-5H3,(H,28,29) FSYSJSBWIFCRBE-UHFFFAOYSA-N 345292 2-[[1-[[2-(Dimethylamino)phenyl]methyl]- 5-(3-methoxyphenyl)pyrazol-3- yl]methoxy]-2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.56 (s, 6H), 2.60 (s, 6H), 6.64 (s, 3H), 4.63 (s, 2H), 5.44 (s, 2H). 6.30 (s, 1H), 6.71-7.11 (m 6H), 7.20- 7.25 (m, 2H).::US10202350, Example 38::US10214492, Example 38::US11292767, Example 38 Malignant T-cell-amplified sequence 1 60000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345292&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124768 385451355 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681971 CC(C)(OCc1cc(-c2cccc(OC3CC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C24H25ClN2O4/c1-24(2,23(28)29)30-15-18-13-22(16-7-5-8-20(12-16)31-19-10-11-19)27(26-18)14-17-6-3-4-9-21(17)25/h3-9,12-13,19H,10-11,14-15H2,1-2H3,(H,28,29) PGLMUSGHACQHIL-UHFFFAOYSA-N 345293 2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopropoxy)phenyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 0.55-0.68 (m 4H), 1.55 (s, 6H), 3.50-3.54 (m 1H), 4.63 (s, 2H), 5.44 (s, 2H), 6.42 (s, 1H), 6.76-7.02 (m, 4H), 7.17-7.35 (m, 4H).::US10202350, Example 39::US10214492, Example 39::US11292767, Example 39 Malignant T-cell-amplified sequence 1 10000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345293&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124603 385451356 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681973 CC(C)(OCc1cc(-c2cccc(CN3CCOCC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C26H30ClN3O4/c1-26(2,25(31)32)34-18-22-15-24(30(28-22)17-21-7-3-4-9-23(21)27)20-8-5-6-19(14-20)16-29-10-12-33-13-11-29/h3-9,14-15H,10-13,16-18H2,1-2H3,(H,31,32) YTZLYWMBUAFPKC-UHFFFAOYSA-N 345294 2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (morpholinomethyl)phenyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid. 1HNMR (CD3OD): $#948; 1.50 (s, 6H), 3.15- 3.23 (bs, 4H), 3.60-3.81 (bs, 2H), 3.85- 4.16 (bs, 2H), 4.35 (s, 2H), 4.57 (s, 2H), 5.45 (s, 2H), 6.60 (s, 1H), 6.75 (d, 1H), 7.20-7.55 (m, 7H).::US10202350, Example 40::US10214492, Example 40::US11292767, Example 40 Malignant T-cell-amplified sequence 1 100000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345294&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124787 385451357 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681975 COc1cccc(c1)-c1cc(COC2(CCC2)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C23H23ClN2O4/c1-29-19-8-4-7-16(12-19)21-13-18(15-30-23(22(27)28)10-5-11-23)25-26(21)14-17-6-2-3-9-20(17)24/h2-4,6-9,12-13H,5,10-11,14-15H2,1H3,(H,27,28) AMBDDVHEOJZXJJ-UHFFFAOYSA-N 345295 1-[[1-[(2-Chlorophenyl)methyl]-5-(3- methoxyphenyl)pyrazol-3- yl]methoxy]cyclobutanecarboxylic acid. 1HNMR (CDCl3): $#948; 1.78-1.85 (m 1H), 1.95-2.04 (m, 2H), 2.18-2.25 (m, 1H), 3.09-3.14 (m, 1H), 3.66 (s, 3H), 4.27-4.32 (m, 1H), 4.55-4.65 (dd, 2H), 5.43 (s, 2H), 6.44 (s, 1H), 6.73-6.91 (m, 4H), 7.17-7.34 (m 4).::US10202350, Example 41::US10214492, Example 41::US11292767, Example 41 Malignant T-cell-amplified sequence 1 100 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345295&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124774 385451358 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681977 CC(C)(OCc1cc(-c2cccc(OCC3CCC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C26H29ClN2O4/c1-26(2,25(30)31)33-17-21-14-24(29(28-21)15-20-9-3-4-12-23(20)27)19-10-6-11-22(13-19)32-16-18-7-5-8-18/h3-4,6,9-14,18H,5,7-8,15-17H2,1-2H3,(H,30,31) OMJMCBRZEPPIAA-UHFFFAOYSA-N 345296 2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclobutylmethoxy)phenyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.55 (s, 6H), 1.75- 1.82 (m, 2H), 1.85-1.98 (m, 2H), 2.06- 2.14 (m, 2H), 2.64-2.70 (m, 1H), 3.71 (d, 2H), 4.63 (s, 2H), 5.43 (s, 2H), 6.42 (s, 1H), 6.75-6.92 (m, 4H), 7.20-7.36 (m, 4).::US10202350, Example 42::US10214492, Example 42::US11292767, Example 42 Malignant T-cell-amplified sequence 1 404 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345296&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124552 385451359 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681979 CC(C)(OCc1cc(-c2cccc(OCC(F)(F)F)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C23H22ClF3N2O4/c1-22(2,21(30)31)33-13-17-11-20(29(28-17)12-16-6-3-4-9-19(16)24)15-7-5-8-18(10-15)32-14-23(25,26)27/h3-11H,12-14H2,1-2H3,(H,30,31) IBKKFBDLZSACSY-UHFFFAOYSA-N 345297 2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (2,2,2-trifluoroethoxy)phenyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.55 (s, 6H), 4.16 (q, 2H), 4.63 (s, 2H), 5.42 (s, 2H), 6.43 (s, 1H), 6.77-6.81 (m, 2H), 6.96-6.98 (m, 2H), 7.19- 7.36 (m, 4H).::US10202350, Example 43::US10214492, Example 43::US11292767, Example 43 Malignant T-cell-amplified sequence 1 33000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345297&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124525 385451360 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681981 CC(C)(OCc1cc(-c2cccc(OCC3CCCC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C27H31ClN2O4/c1-27(2,26(31)32)34-18-22-15-25(30(29-22)16-21-10-5-6-13-24(21)28)20-11-7-12-23(14-20)33-17-19-8-3-4-9-19/h5-7,10-15,19H,3-4,8-9,16-18H2,1-2H3,(H,31,32) ZRXMBBHQLHYREE-UHFFFAOYSA-N 345298 2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopentylmethoxy)phenyl]pyrazol-3- yl]methoxy]-2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.25-1.29 (m, 2H), 1.55-1.61 (m, 10H), 1.76-1.79 (m, 2H), 2.24-2.31 (m, 1H), 3.59 (d, 2H), 4.62 (s, 2H), 5.43 (s, 2H), 6.41 (s, 1H), 6.73-6.91 (m, 4H), 7.19-7.35 (m, 4H).::US10202350, Example 44::US10214492, Example 44::US11292767, Example 44 Malignant T-cell-amplified sequence 1 204 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345298&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124580 385451361 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681983 CC(C)(OCc1cc(-c2cccc(OCC3CCOCC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C27H31ClN2O5/c1-27(2,26(31)32)35-18-22-15-25(30(29-22)16-21-6-3-4-9-24(21)28)20-7-5-8-23(14-20)34-17-19-10-12-33-13-11-19/h3-9,14-15,19H,10-13,16-18H2,1-2H3,(H,31,32) IYFRTLKCGOPSHI-UHFFFAOYSA-N 345299 2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (tetrahydropyran-4- ylmethoxy)phenyl]pyrazol-3-yl]methoxy]- 2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.34-1.41 (m, 2H), 1.55 (s, 6H), 1.66-1.69 (m, 2H), 1.97- 1.99 (m, 1H), 3.38-3.46m, 2H), 3.56 (d, 2H), 3.98-4.01 (m, 2H), 4.62 (s, 2H), 5.42 (s, 2H), 6.42 (s, 1H), 6.71 (s, 1H), 6.77-6.95 (m, 3H), 7.19-7.35 (m, 4H).::US10202350, Example 45::US10214492, Example 45::US11292767, Example 45 Malignant T-cell-amplified sequence 1 12000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345299&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124607 385451362 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681985 CC(C)(OCc1cc(-c2cccc(c2)N2CCOCC2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C25H28ClN3O4/c1-25(2,24(30)31)33-17-20-15-23(29(27-20)16-19-6-3-4-9-22(19)26)18-7-5-8-21(14-18)28-10-12-32-13-11-28/h3-9,14-15H,10-13,16-17H2,1-2H3,(H,30,31) IHKMRHBZXGHGKV-UHFFFAOYSA-N 345300 2-[[1-[(2-Chlorophenyl)methyl]-5-(3- morpholinophenyl)pyrazol-3-yl]methoxy]- 2-methyl-propanoic acid. 1HNMR (CDCl3): $#948; 1.55 (s, 6H), 2.96 (t, 4H), 3.76 (t, 4H), 4.62 (s, 2H), 5.41 (s, 2H), 6.41 (s, 1H), 6.68 (s, 1H), 6.78-6.80 (m, 2H), 6.88-6.91 (m, 1H), 7.19-7.35 (m, 4H).::US10202350, Example 46::US10214492, Example 46::US11292767, Example 46 Malignant T-cell-amplified sequence 1 47000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345300 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345300&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124608 385451363 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681987 CC(C)(OCc1cc(-c2cscn2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C18H18ClN3O3S/c1-18(2,17(23)24)25-9-13-7-16(15-10-26-11-20-15)22(21-13)8-12-5-3-4-6-14(12)19/h3-7,10-11H,8-9H2,1-2H3,(H,23,24) BLDHBBKXCWXTTI-UHFFFAOYSA-N 345301 2-([1-[(o-Chlorophenyl)methyl]-5-(1,3- thiazol-4-yl)-1H-pyrazol-3-yl]methoxy)-2- methylpropionic acid 1HNMR (CDCl3): $#948; 1.56 (s, 6H), 4.63 (s, 2H), 5.84 (s, 2H), 6.62-6.67 (m, 2H), 7.10- 7.19 (m 2H), 7.33-7.35 (m, 1H), 7.39 (d, 1H), 8.83 (d, 1H).::US10202350, Example 47::US10214492, Example 47::US11292767, Example 47 Malignant T-cell-amplified sequence 1 100000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345301 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345301&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129072 385451364 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681989 CC(C)(OCc1cc(-c2cccc(c2)C#N)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C22H20ClN3O3/c1-22(2,21(27)28)29-14-18-11-20(16-8-5-6-15(10-16)12-24)26(25-18)13-17-7-3-4-9-19(17)23/h3-11H,13-14H2,1-2H3,(H,27,28) HMOQKCFYUAPPSL-UHFFFAOYSA-N 345302 2-([1-[(o-Chlorophenyl)methyl]-5-(m- cyanophenyl)-1H-pyrazol-3-yl]methoxy)- 2-methylpropionic acid 1HNMR (CDCl3): $#948; 1.56 (s, 6H), 4.62 (s, 2H), 5.39 (s, 2H), 6.46 (s, 1H), 6.82-6.84 (m, 1H), 7.18-7.24 (m, 2H), 7.33-7.35 (m 1H), 7.46-7.55 (m, 3H), 7.65-7.68 (m, 1H).::US10202350, Example 48::US10214492, Example 48::US11292767, Example 48 Malignant T-cell-amplified sequence 1 55000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345302 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345302&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129073 385451365 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681991 CC(C)(OCc1cc(-c2cncs2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C18H18ClN3O3S/c1-18(2,17(23)24)25-10-13-7-15(16-8-20-11-26-16)22(21-13)9-12-5-3-4-6-14(12)19/h3-8,11H,9-10H2,1-2H3,(H,23,24) OLGOBMVSZDXCHY-UHFFFAOYSA-N 345303 2-([1-[(o-Chlorophenyl)methyl]-5-(1,3- thiazol-5-yl)-1H-pyrazol-3-yl]methoxy)-2- methylpropionic acid 1HNMR (CDCl3): $#948; 1.56 (s, 6H), 4.62 (s, 2H), 5.50 (s, 2H), 6.60-6.6 (m, 2H), 7.14- 7.24 (m, 2H), 7.36-7.38 (m, 1H), 7.76 (s, 1H), 8.84 (s, 1H).::US10202350, Example 49::US10214492, Example 49::US11292767, Example 49 Malignant T-cell-amplified sequence 1 130000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345303&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129074 385451366 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681993 CN(C)c1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C23H26ClN3O3/c1-23(2,22(28)29)30-15-18-13-21(16-9-7-10-19(12-16)26(3)4)27(25-18)14-17-8-5-6-11-20(17)24/h5-13H,14-15H2,1-4H3,(H,28,29) VTRBRHCKQXQWMO-UHFFFAOYSA-N 345304 2-([1-[(o-Chlorophenyl)methyl]-5-[m- (dimethylamino)phenyl]-1H-pyrazol-3- yl]methoxy)-2-methylpropionic acid MS: Calculated: 427.92; Found: 428.9 [M + H].::US10202350, Example 50::US10214492, Example 50::US11292767, Example 50 Malignant T-cell-amplified sequence 1 34000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345304 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345304&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124533 385451367 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681995 CC(C)c1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C24H27ClN2O3/c1-16(2)17-9-7-10-18(12-17)22-13-20(15-30-24(3,4)23(28)29)26-27(22)14-19-8-5-6-11-21(19)25/h5-13,16H,14-15H2,1-4H3,(H,28,29) PBSULNYVRQWPIF-UHFFFAOYSA-N 345305 US10202350, Example 51::US10214492, Example 51::US11292767, Example 51 Malignant T-cell-amplified sequence 1 6000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345305&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124545 385451368 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681997 COCc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C23H25ClN2O4/c1-23(2,22(27)28)30-15-19-12-21(17-9-6-7-16(11-17)14-29-3)26(25-19)13-18-8-4-5-10-20(18)24/h4-12H,13-15H2,1-3H3,(H,27,28) OLKQLMCRWXDNLF-UHFFFAOYSA-N 345306 2-([1-[(2-chlorophenyl)methyl]-5-[3- (methoxymethyl)phenyl]-1H-pyrazol-3- yl]methoxy)-2-methylpropanoic acid 1H-NMR (300 MHz, MeOD): $#948; 1.52 (6 H, s), 4.42 (2 H, s), 4.59 (2 H, s), 5.42 (2 H, s), 6.56 (1 H, s), 6.70-6.80 (1 H, m), 7.17-7.33 (4 H, m), 7.32-7.45 (3 H, m).::US10202350, Example 52::US10214492, Example 52::US11292767, Example 52 Malignant T-cell-amplified sequence 1 84000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345306&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129076 385451369 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 681999 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1 InChI=1S/C22H24N2O4/c1-22(2,21(25)26)28-15-18-13-20(17-10-7-11-19(12-17)27-3)24(23-18)14-16-8-5-4-6-9-16/h4-13H,14-15H2,1-3H3,(H,25,26) WHSHCPPJSPWGEU-UHFFFAOYSA-N 345307 2-[[1-benzyl-5-(3-methoxyphenyl)-1H- pyrazol-3-yl]methoxy]-2-methylpropanoic acid [0247] 1H-NMR (300 MHz, MeOD) $#948; 1.51 (6 H, s), 3.68 (3 H, s), 4.57 (2 H, s), 5.35 (2 H, s), 6.48 (1 H, s), 6.84 (1 H, dd), 6.89-7.06 (4 H, m), 7.17-7.38 (4 H, m).::US10202350, Example 53::US10214492, Example 53::US11292767, Example 53 Malignant T-cell-amplified sequence 1 100000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345307 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345307&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124547 385451370 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682001 COc1cccc(c1)-c1c(C)c(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C23H25ClN2O4/c1-15-20(14-30-23(2,3)22(27)28)25-26(13-17-8-5-6-11-19(17)24)21(15)16-9-7-10-18(12-16)29-4/h5-12H,13-14H2,1-4H3,(H,27,28) OKPPJNRDLNLAOL-UHFFFAOYSA-N 345308 2-({1-[(o-Chlorophenyl)methyl]-5-(m- methoxyphenyl)-4-methyl-1H-pyrazol-3- yl}methoxy)-2-methylpropionic acid 1H-NMR: (300 MHz, MeOD) $#948; 1.53 (6 H, s), 2.09 (3 H, s), 3.67 (3 H, s), 4.60 (2 H, s), 5.31 (2 H, s), 6.67-6.86 (3 H, m), 6.97 (1 H, ddd), 7.17-7.40 (4 H, m).::US10202350, Example 54::US10214492, Example 54::US11292767, Example 54 Malignant T-cell-amplified sequence 1 27000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345308&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129078 385451371 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682003 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1-c1ccccc1 InChI=1S/C21H22N2O4/c1-21(2,20(24)25)27-14-16-13-19(15-8-7-11-18(12-15)26-3)23(22-16)17-9-5-4-6-10-17/h4-13H,14H2,1-3H3,(H,24,25) WTQWVXOIPVWCNO-UHFFFAOYSA-N 345309 2-[[5-(3-methoxyphenyl)-1-phenyl-1H- pyrazol-3-yl]methoxy]-2-methylpropanoic acid [0248] 1H-NMR (300 MHz, MeOD) $#948; 1.53 (6 H, s), 3.64 (3 H, s), 4.61 (2 H, s), 6.63-6.77 (2 H, m), 6.77-6.93 (2 H, m), 7.16-7.36 (3 H, m), 7.40 (3 H, dddd).::US10202350, Example 55::US10214492, Example 55::US11292767, Example 55 Malignant T-cell-amplified sequence 1 100000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345309 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345309&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124585 385451372 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682005 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1-c1ccccn1 InChI=1S/C20H21N3O4/c1-20(2,19(24)25)27-13-15-12-17(14-7-6-8-16(11-14)26-3)23(22-15)18-9-4-5-10-21-18/h4-12H,13H2,1-3H3,(H,24,25) QJAGQGMNVGHNNO-UHFFFAOYSA-N 345310 2-[[5-(3-methoxyphenyl)-1-(pyridin-2-yl)- 1H-pyrazol-3-yl]methoxy]-2- methylpropanoic acid LC-MS (ES, m/z): 367 1H-NMR (400 MHz, MeOD) $#948; 1.54 (6 H, s), 3.69 (3 H, s), 4.65 (2 H, s), 6.70 (1 H, s), 6.76- 6.78 (2 H, m), 6.89 (1 H, ddd), 7.20-7.25 (1H, d), 7.41-7.45 (2H, m), 7.91 (1 H, dt), 8.41 (1 H, t).::US10202350, Example 56::US10214492, Example 56::US11292767, Example 56 Malignant T-cell-amplified sequence 1 133000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345310 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345310&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124583 385451373 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682007 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1-c1ccccc1Cl InChI=1S/C21H21ClN2O4/c1-21(2,20(25)26)28-13-15-12-19(14-7-6-8-16(11-14)27-3)24(23-15)18-10-5-4-9-17(18)22/h4-12H,13H2,1-3H3,(H,25,26) OOJFMEQRAVLTMY-UHFFFAOYSA-N 345311 2-[[1-(2-chlorophenyl)-5-(3-methoxyphenyl)- 1H-pyrazol-3-yl]methoxy]-2- methylpropanoic acid LC-MS (ES, m/z): 401 1H-NMR (400 MHz, MeOD) $#948; 1.55 (6 H, s), 3.64 (3 H, s), 4.63 (2 H, s), 6.73 (2 H, d), 6.86 (2 H, dd), 7.20 (1 H, dd), 7.42-7.60 (4 H, m).::US10202350, Example 57::US10214492, Example 57::US11292767, Example 57 Malignant T-cell-amplified sequence 1 133000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345311&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124579 385451374 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682009 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1-c1cccc(Cl)c1 InChI=1S/C21H21ClN2O4/c1-21(2,20(25)26)28-13-16-12-19(14-6-4-9-18(10-14)27-3)24(23-16)17-8-5-7-15(22)11-17/h4-12H,13H2,1-3H3,(H,25,26) DIQFPXILUDHPLV-UHFFFAOYSA-N 345312 2-[[1-(3-chlorophenyl)-5-(3-methoxyphenyl)- 1H-pyrazol-3-yl]methoxy]-2- methylpropanoic acid 1H-NMR (400 MHz, MeOD) $#948; 1.54 (6 H, s), 3.71 (3 H, s), 4.62 (2 H, s), 6.68 (1 H, s), 6.77- 6.87 (2 H, m), 6.94 (1 H, ddd), 7.19 (1 H, dt), 7.27 (1 H, t), 7.32-7.44 (3 H, m).::US10202350, Example 58::US10214492, Example 58::US11292767, Example 58 Malignant T-cell-amplified sequence 1 78000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345312&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129077 385451375 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682011 COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1-c1ccc(Cl)cc1 InChI=1S/C21H21ClN2O4/c1-21(2,20(25)26)28-13-16-12-19(14-5-4-6-18(11-14)27-3)24(23-16)17-9-7-15(22)8-10-17/h4-12H,13H2,1-3H3,(H,25,26) ODEHXQRAHIJXOU-UHFFFAOYSA-N 345313 2-[[1-(4-chlorophenyl)-5-(3-methoxyphenyl)- 1H-pyrazol-3-yl]methoxy]-2- methylpropanoic acid LC-MS (ES, m/z): 401 1H-NMR (400 MHz, MeOD) $#948; 1.54 (6 H, s), 3.71 (3 H, s), 4.62 (2 H, s), 6.67 (1 H, s), 6.75- 6.85 (2 H, m), 6.92 (1 H, ddd), 7.21-7.32 (3 H, m), 7.37-7.46 (2 H, m).::US10202350, Example 59::US10214492, Example 59::US11292767, Example 59 Malignant T-cell-amplified sequence 1 81000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345313&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124529 385451376 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682013 CC(C)COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1 InChI=1S/C25H30N2O4/c1-18(2)16-30-22-12-8-11-20(13-22)23-14-21(17-31-25(3,4)24(28)29)26-27(23)15-19-9-6-5-7-10-19/h5-14,18H,15-17H2,1-4H3,(H,28,29) RJVMEVXTVLYGKR-UHFFFAOYSA-N 345314 US10202350, Example 60::US10214492, Example 60::US11292767, Example 60 Malignant T-cell-amplified sequence 1 44000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345314&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124606 385451377 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682015 COc1ccccc1Cn1nc(COC(C)(C)C(O)=O)cc1-c1cccc(OCC(C)C)c1 InChI=1S/C26H32N2O5/c1-18(2)16-32-22-11-8-10-19(13-22)23-14-21(17-33-26(3,4)25(29)30)27-28(23)15-20-9-6-7-12-24(20)31-5/h6-14,18H,15-17H2,1-5H3,(H,29,30) AIFPDSKICGNNQE-UHFFFAOYSA-N 345315 2-([1-[(2-methoxyphenyl)methyl]-5-[3-(2- methylpropoxy)phenyl]-1H-pyrazol-3- yl]methoxy)-2-methylpropanoic acid LC-MS (ES, m/z): 453 1H-NMR (400 MHz, MeOD) $#948; 0.97 (6 H, d), 1.53 (6 H, s), 1.97 (1 H, dp), 3.48 (2 H, d), 3.78 (3 H, s), 4.58 (2 H, s), 5.31 (2 H, s), 6.52 (1 H, s), 6.67-6.74 (1 H, m), 6.76- 6.82 (1 H, m), 6.85-7.00 (4 H, m), 7.22- 7.33 (2 H, m).::US10202350, Example 61::US10214492, Example 61::US11292767, Example 61 Malignant T-cell-amplified sequence 1 11000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345315&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124587 385451378 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682017 COc1cccc(Cn2nc(COC(C)(C)C(O)=O)cc2-c2cccc(OCC(C)C)c2)c1 InChI=1S/C26H32N2O5/c1-18(2)16-32-23-11-7-9-20(13-23)24-14-21(17-33-26(3,4)25(29)30)27-28(24)15-19-8-6-10-22(12-19)31-5/h6-14,18H,15-17H2,1-5H3,(H,29,30) PDHQCLVRQDHDKY-UHFFFAOYSA-N 345316 2-([1-[(3-methoxyphenyl)methyl]-5-[3-(2- methylpropoxy)phenyl]-1H-pyrazol-3- yl]methoxy)-2-methylpropanoic acid LC-MS (ES, m/z): 453 1H-NMR (400 MHz, MeOD) $#948; 0.99 (6 H, d), 1.53 (6 H, s), 1.99 (1 H, dq), 3.55 (2 H, d), 3.73 (3 H, s), 4.59 (2 H, s), 5.33 (2 H, s), 6.50 (1 H, s), 6.56-6.65 (2 H, m), 6.78- 6.86 (2 H, m), 6.92-7.00 (2 H, m), 7.22 (1 H, t), 7.33 (1 H, t).::US10202350, Example 62::US10214492, Example 62::US11292767, Example 62 Malignant T-cell-amplified sequence 1 27000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345316&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124631 385451379 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682019 COc1ccc(Cn2nc(COC(C)(C)C(O)=O)cc2-c2cccc(OCC(C)C)c2)cc1 InChI=1S/C26H32N2O5/c1-18(2)16-32-23-8-6-7-20(13-23)24-14-21(17-33-26(3,4)25(29)30)27-28(24)15-19-9-11-22(31-5)12-10-19/h6-14,18H,15-17H2,1-5H3,(H,29,30) WGPMMRULSHPCIV-UHFFFAOYSA-N 345317 2-([1-[(4-methoxyphenyl)methyl]-5-[3-(2- methylpropoxy)phenyl]-1H-pyrazol-3- yl]methoxy)-2-methylpropanoic acid LC-MS (ES, m/z): 453 1H-NMR (400 MHz, MeOD) $#948; 1.00 (6 H, d), 1.53 (6 H, s), 2.01 (1 H, dp), 3.57 (2 H, d), 3.77 (3 H, s), 4.58 (2 H, s), 5.29 (2 H, s), 6.47 (1 H, s), 6.78-6.90 (3 H, m), 6.92- 7.01 (4 H, m), 7.29-7.39 (1 H, m).::US10202350, Example 63::US10214492, Example 63::US11292767, Example 63 Malignant T-cell-amplified sequence 1 17000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345317 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345317&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124781 385451380 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682021 COc1ccc(s1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C20H21ClN2O4S/c1-20(2,19(24)25)27-12-14-10-16(17-8-9-18(26-3)28-17)23(22-14)11-13-6-4-5-7-15(13)21/h4-10H,11-12H2,1-3H3,(H,24,25) COUMSONLMUNMPZ-UHFFFAOYSA-N 345318 US10202350, Example 64::US10214492, Example 64::US11292767, Example 64 Malignant T-cell-amplified sequence 1 45000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345318 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345318&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124780 385451381 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682023 COc1csc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C20H21ClN2O4S/c1-20(2,19(24)25)27-11-14-8-17(18-9-15(26-3)12-28-18)23(22-14)10-13-6-4-5-7-16(13)21/h4-9,12H,10-11H2,1-3H3,(H,24,25) KWQFQMAZQOFYGO-UHFFFAOYSA-N 345319 US10202350, Example 65::US10214492, Example 65::US11292767, Example 65 Malignant T-cell-amplified sequence 1 13000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345319&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124602 385451382 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682025 COc1cc(cs1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C20H21ClN2O4S/c1-20(2,19(24)25)27-11-15-9-17(14-8-18(26-3)28-12-14)23(22-15)10-13-6-4-5-7-16(13)21/h4-9,12H,10-11H2,1-3H3,(H,24,25) SSCBADQNXLRGFC-UHFFFAOYSA-N 345320 2-([1-[(2-chlorophenyl)methyl]-5-(5-methoxythiophen-3-yl)-1H-pyrazol-3-yl]methoxy)-2-methylpropanoic Acid::US10202350, Example 66::US10214492, Example 66::US11292767, Example 66 Malignant T-cell-amplified sequence 1 45000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345320 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345320&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124647 385451383 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682027 CCC(CC)(OCc1cc(-c2cccc(OC)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C24H27ClN2O4/c1-4-24(5-2,23(28)29)31-16-19-14-22(17-10-8-11-20(13-17)30-3)27(26-19)15-18-9-6-7-12-21(18)25/h6-14H,4-5,15-16H2,1-3H3,(H,28,29) ZTNRFRRMVBDPHU-UHFFFAOYSA-N 345321 2-([1-(o-Chlorophenyl)methyl]-5-(m-methoxyphenyl)-1H-pyrazol-3-yl)methoxy)-2-ethylbutyric Acid::US10202350, Example 67::US10214492, Example 67::US11292767, Example 67 Malignant T-cell-amplified sequence 1 17000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345321&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124129080 385451384 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682029 CCC(C)(OCc1cc(-c2cccc(OC)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C23H25ClN2O4/c1-4-23(2,22(27)28)30-15-18-13-21(16-9-7-10-19(12-16)29-3)26(25-18)14-17-8-5-6-11-20(17)24/h5-13H,4,14-15H2,1-3H3,(H,27,28) JQLFQSDGPXAFLG-UHFFFAOYSA-N 345322 2-([1-[(2-Chlorophenyl)methyl]-5-(3-methoxyphenyl)-1H-pyrazol-3-yl]methoxy)-2-methylbutanoic Acid::US10202350, Example 68::US10214492, Example 68::US11292767, Example 68 Malignant T-cell-amplified sequence 1 26000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345322&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124651 385451385 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682031 CC(C)C(=O)Nc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C25H28ClN3O4/c1-16(2)23(30)27-19-10-7-9-17(12-19)22-13-20(15-33-25(3,4)24(31)32)28-29(22)14-18-8-5-6-11-21(18)26/h5-13,16H,14-15H2,1-4H3,(H,27,30)(H,31,32) CKBBYNPEIRWJFZ-UHFFFAOYSA-N 345323 US10202350, Example 69::US10214492, Example 69::US11292767, Example 69 Malignant T-cell-amplified sequence 1 100000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345323&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124541 385451386 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682033 CC(C)(OCc1cc(-c2cccc(c2)S(C)(=O)=O)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C22H23ClN2O5S/c1-22(2,21(26)27)30-14-17-12-20(15-8-6-9-18(11-15)31(3,28)29)25(24-17)13-16-7-4-5-10-19(16)23/h4-12H,13-14H2,1-3H3,(H,26,27) DDEBXIFATYDBAE-UHFFFAOYSA-N 345324 US10202350, Example 70::US10214492, Example 70::US11292767, Example 70 Malignant T-cell-amplified sequence 1 100000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345324 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345324&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124551 385451387 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682035 CC(C)(OCc1cc(-c2cccc(NS(C)(=O)=O)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C22H24ClN3O5S/c1-22(2,21(27)28)31-14-18-12-20(15-8-6-9-17(11-15)25-32(3,29)30)26(24-18)13-16-7-4-5-10-19(16)23/h4-12,25H,13-14H2,1-3H3,(H,27,28) GXMGBJOUZFPMNJ-UHFFFAOYSA-N 345325 US10202350, Example 71::US10214492, Example 71::US11292767, Example 71 Malignant T-cell-amplified sequence 1 64000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345325&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124531 385451388 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682037 CNc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C22H24ClN3O3/c1-22(2,21(27)28)29-14-18-12-20(15-8-6-9-17(11-15)24-3)26(25-18)13-16-7-4-5-10-19(16)23/h4-12,24H,13-14H2,1-3H3,(H,27,28) GYRKVCJUPRUJEH-UHFFFAOYSA-N 345326 US10202350, Example 72::US10214492, Example 72::US11292767, Example 72 Malignant T-cell-amplified sequence 1 45000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345326 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345326&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124534 385451389 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682039 CC(C)CNc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C25H30ClN3O3/c1-17(2)14-27-20-10-7-9-18(12-20)23-13-21(16-32-25(3,4)24(30)31)28-29(23)15-19-8-5-6-11-22(19)26/h5-13,17,27H,14-16H2,1-4H3,(H,30,31) WQZFCYYDFUDHRZ-UHFFFAOYSA-N 345327 2-([1-[(2-chlorophenyl)methyl]-5-[3-[(2-methylpropyl)amino]phenyl]-1H-pyrazol-3-yl]methoxy)-2-methylpropanoic Acid::US10202350, Example 73::US10214492, Example 73::US11292767, Example 73 Malignant T-cell-amplified sequence 1 11000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345327&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124622 385451390 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682041 CC(C)NC(=O)c1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl InChI=1S/C25H28ClN3O4/c1-16(2)27-23(30)18-10-7-9-17(12-18)22-13-20(15-33-25(3,4)24(31)32)28-29(22)14-19-8-5-6-11-21(19)26/h5-13,16H,14-15H2,1-4H3,(H,27,30)(H,31,32) RXMXTDGMCOMRSW-UHFFFAOYSA-N 345328 US10202350, Example 74::US10214492, Example 74::US11292767, Example 74 Malignant T-cell-amplified sequence 1 100000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345328 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345328&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124575 385451391 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682043 CC(C)(OCc1cc(Nc2ccccc2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C21H22ClN3O3/c1-21(2,20(26)27)28-14-17-12-19(23-16-9-4-3-5-10-16)25(24-17)13-15-8-6-7-11-18(15)22/h3-12,23H,13-14H2,1-2H3,(H,26,27) XGGFUXRSHDHEEC-UHFFFAOYSA-N 345329 US10202350, Example 75::US10214492, Example 75::US11292767, Example 75 Malignant T-cell-amplified sequence 1 100000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345329&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124629 385451392 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682045 CC(C)(OCc1cc(Oc2ccccc2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C21H21ClN2O4/c1-21(2,20(25)26)27-14-16-12-19(28-17-9-4-3-5-10-17)24(23-16)13-15-8-6-7-11-18(15)22/h3-12H,13-14H2,1-2H3,(H,25,26) XSTYAYQYYWIOHQ-UHFFFAOYSA-N 345330 US10202350, Example 76::US10214492, Example 76::US11292767, Example 76 Malignant T-cell-amplified sequence 1 38000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345330 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345330&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124555 385451393 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682047 CC(C)(OCc1cc(Cc2ccccc2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C22H23ClN2O3/c1-22(2,21(26)27)28-15-18-13-19(12-16-8-4-3-5-9-16)25(24-18)14-17-10-6-7-11-20(17)23/h3-11,13H,12,14-15H2,1-2H3,(H,26,27) YYAKIQWVSMWZOZ-UHFFFAOYSA-N 345331 US10202350, Example 77::US10214492, Example 77::US11292767, Example 77 Malignant T-cell-amplified sequence 1 9000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345331&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124653 385451394 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682049 CC(C)(OCc1cc(-c2cccc(O)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C21H21ClN2O4/c1-21(2,20(26)27)28-13-16-11-19(14-7-5-8-17(25)10-14)24(23-16)12-15-6-3-4-9-18(15)22/h3-11,25H,12-13H2,1-2H3,(H,26,27) ISXYNCMWBCNIMG-UHFFFAOYSA-N 345332 2-[[1-[(2-Chlorophenyl)methyl]-5-(3-hydroxyphenyl)pyrazol-3-yl]methoxy]-2-methyl-propanoic Acid::US10202350, Example 79::US10214492, Example 79::US11292767, Example 79 Malignant T-cell-amplified sequence 1 15000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345332&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124530 385451395 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682051 CC(C)(OCc1cc(-c2cccc(OCC3COC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O InChI=1S/C25H27ClN2O5/c1-25(2,24(29)30)33-16-20-11-23(28(27-20)12-19-6-3-4-9-22(19)26)18-7-5-8-21(10-18)32-15-17-13-31-14-17/h3-11,17H,12-16H2,1-2H3,(H,29,30) AKHKLJGNKQYKOE-UHFFFAOYSA-N 345333 US10202350, Example 80::US10214492, Example 80::US11292767, Example 80 Malignant T-cell-amplified sequence 1 61000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345333&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124601 385451396 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682053 COc1cccc(c1)-c1cc(COC(C)(C)C(=O)NS(C)(=O)=O)nn1Cc1ccccc1Cl InChI=1S/C23H26ClN3O5S/c1-23(2,22(28)26-33(4,29)30)32-15-18-13-21(16-9-7-10-19(12-16)31-3)27(25-18)14-17-8-5-6-11-20(17)24/h5-13H,14-15H2,1-4H3,(H,26,28) IRHLEONWFSXRDD-UHFFFAOYSA-N 345334 US10202350, Example 81::US10214492, Example 81::US11292767, Example 81 Malignant T-cell-amplified sequence 1 303 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345334&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124630 385451397 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 682055 COC(=O)C(C)(C)OCc1cc(-c2cccc(OC)c2)n(Cc2ccccc2Cl)n1 InChI=1S/C23H25ClN2O4/c1-23(2,22(27)29-4)30-15-18-13-21(16-9-7-10-19(12-16)28-3)26(25-18)14-17-8-5-6-11-20(17)24/h5-13H,14-15H2,1-4H3 QHUJIOGPQRJMNO-UHFFFAOYSA-N 345335 Methyl 2-[[1-[(2-chlorophenyl)methyl]-5-(3-methoxyphenyl)pyrazol-3-yl]methoxy]-2-methyl-propanoate::US10202350, Example 82::US10214492, Example 82::US11292767, Example 82 Malignant T-cell-amplified sequence 1 16000 US Patent 10.7270/Q20K2BPB aid1797283 US10202350 Parnell, KM; McCall, J Vettore, LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=345335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=345335&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 124124610 385451398 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805770 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cccc(CO)c3F)c2c(=O)n(C)c1=O InChI=1S/C24H27FN4O3S/c1-12(2)10-29-23-20(22(31)28(5)24(29)32)19(16-8-6-7-15(11-30)21(16)25)18(33-23)9-17-13(3)26-27-14(17)4/h6-8,12,30H,9-11H2,1-5H3,(H,26,27) VGXVSHJDGJTLJG-UHFFFAOYSA-N 402876 US10329303, Example 1 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402876&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122432416 405262855 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805771 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cc(C)cc(CO)c3F)c2c(=O)n(C)c1=O InChI=1S/C25H29FN4O3S/c1-12(2)10-30-24-21(23(32)29(6)25(30)33)20(18-8-13(3)7-16(11-31)22(18)26)19(34-24)9-17-14(4)27-28-15(17)5/h7-8,12,31H,9-11H2,1-6H3,(H,27,28) FYAQNUUFGKLTNB-UHFFFAOYSA-N 402882 US10329303, Example 2 Malignant T-cell-amplified sequence 1 100.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402882&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 76401628 405262861 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805772 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3c(F)cc(F)c(CO)c3F)c2c(=O)n(C)c1=O InChI=1S/C24H25F3N4O3S/c1-10(2)8-31-23-20(22(33)30(5)24(31)34)19(17(35-23)6-13-11(3)28-29-12(13)4)18-16(26)7-15(25)14(9-32)21(18)27/h7,10,32H,6,8-9H2,1-5H3,(H,28,29) JDFHDAQQHRCWFY-UHFFFAOYSA-N 402974 US10329303, Example 3 Malignant T-cell-amplified sequence 1 5500 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402974&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 76401631 405262951 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805773 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cnc(F)c(CO)c3)c2c(=O)n(C)c1=O InChI=1S/C23H26FN5O3S/c1-11(2)9-29-22-19(21(31)28(5)23(29)32)18(14-6-15(10-30)20(24)25-8-14)17(33-22)7-16-12(3)26-27-13(16)4/h6,8,11,30H,7,9-10H2,1-5H3,(H,26,27) SOSFMQAUOYIHQR-UHFFFAOYSA-N 402975 US10329303, Example 4 Malignant T-cell-amplified sequence 1 200 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402975&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 76401613 405262952 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805774 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cc(F)c(F)c(CO)c3)c2c(=O)n(C)c1=O InChI=1S/C24H26F2N4O3S/c1-11(2)9-30-23-20(22(32)29(5)24(30)33)19(14-6-15(10-31)21(26)17(25)7-14)18(34-23)8-16-12(3)27-28-13(16)4/h6-7,11,31H,8-10H2,1-5H3,(H,27,28) RIZQMCNEYDNEFY-UHFFFAOYSA-N 403025 US10329303, Example 5 Malignant T-cell-amplified sequence 1 160 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403025&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 73508028 405263001 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805775 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cc(CO)c(F)cc3F)c2c(=O)n(C)c1=O InChI=1S/C24H26F2N4O3S/c1-11(2)9-30-23-21(22(32)29(5)24(30)33)20(16-6-14(10-31)17(25)8-18(16)26)19(34-23)7-15-12(3)27-28-13(15)4/h6,8,11,31H,7,9-10H2,1-5H3,(H,27,28) AHLURGFBUMDAFW-UHFFFAOYSA-N 403040 US10329303, Example 6 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403040 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403040&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 73438602 405263016 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805776 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3ccc(F)c(CO)c3F)c2c(=O)n(C)c1=O InChI=1S/C24H26F2N4O3S/c1-11(2)9-30-23-20(22(32)29(5)24(30)33)19(14-6-7-17(25)16(10-31)21(14)26)18(34-23)8-15-12(3)27-28-13(15)4/h6-7,11,31H,8-10H2,1-5H3,(H,27,28) HRUHNBHIUSQWBT-UHFFFAOYSA-N 403041 US10329303, Example 7 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403041&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424393 405263017 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805777 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cncc(c3)C(O)C(F)(F)F)c2c(=O)n(C)c1=O InChI=1S/C24H26F3N5O3S/c1-11(2)10-32-22-19(21(34)31(5)23(32)35)18(17(36-22)7-16-12(3)29-30-13(16)4)14-6-15(9-28-8-14)20(33)24(25,26)27/h6,8-9,11,20,33H,7,10H2,1-5H3,(H,29,30) GUECJEUCWGAKSH-UHFFFAOYSA-N 403059 US10329303, Example 8 Malignant T-cell-amplified sequence 1 34.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403059&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 76401616 405263035 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805778 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3ccc(F)c(CO)c3)c2c(=O)n(C)c1=O InChI=1S/C24H27FN4O3S/c1-12(2)10-29-23-21(22(31)28(5)24(29)32)20(15-6-7-18(25)16(8-15)11-30)19(33-23)9-17-13(3)26-27-14(17)4/h6-8,12,30H,9-11H2,1-5H3,(H,26,27) UDULIHXORZBJCF-UHFFFAOYSA-N 403093 US10329303, Example 9 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403093&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424320 405263068 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805779 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3ccnc(CO)c3)c2c(=O)n(C)c1=O InChI=1S/C23H27N5O3S/c1-12(2)10-28-22-20(21(30)27(5)23(28)31)19(15-6-7-24-16(8-15)11-29)18(32-22)9-17-13(3)25-26-14(17)4/h6-8,12,29H,9-11H2,1-5H3,(H,25,26) XWQOAHYLZSHHFN-UHFFFAOYSA-N 403094 US10329303, Example 10 Malignant T-cell-amplified sequence 1 90.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403094&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424217 405263069 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805780 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cc(F)cc(CO)c3)c2c(=O)n(C)c1=O InChI=1S/C24H27FN4O3S/c1-12(2)10-29-23-21(22(31)28(5)24(29)32)20(16-6-15(11-30)7-17(25)8-16)19(33-23)9-18-13(3)26-27-14(18)4/h6-8,12,30H,9-11H2,1-5H3,(H,26,27) PIYNXYNEOZTURP-UHFFFAOYSA-N 403095 US10329303, Example 11 Malignant T-cell-amplified sequence 1 25.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403095&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424452 405263070 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805781 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cncc(CO)c3)c2c(=O)n(C)c1=O InChI=1S/C23H27N5O3S/c1-12(2)10-28-22-20(21(30)27(5)23(28)31)19(16-6-15(11-29)8-24-9-16)18(32-22)7-17-13(3)25-26-14(17)4/h6,8-9,12,29H,7,10-11H2,1-5H3,(H,25,26) LFAQGQBGEOSMCO-UHFFFAOYSA-N 403109 US10329303, Example 12 Malignant T-cell-amplified sequence 1 75.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403109&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424310 405263084 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805782 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cccc(c3)C(C)O)c2c(=O)n(C)c1=O InChI=1S/C25H30N4O3S/c1-13(2)12-29-24-22(23(31)28(6)25(29)32)21(18-9-7-8-17(10-18)16(5)30)20(33-24)11-19-14(3)26-27-15(19)4/h7-10,13,16,30H,11-12H2,1-6H3,(H,26,27) HKJANQZDSCTIQE-UHFFFAOYSA-N 403111 US10329303, Example 13 Malignant T-cell-amplified sequence 1 50.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403111&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424206 405263086 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805783 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cccc(c3)C(O)C(F)(F)F)c2c(=O)n(C)c1=O InChI=1S/C25H27F3N4O3S/c1-12(2)11-32-23-20(22(34)31(5)24(32)35)19(18(36-23)10-17-13(3)29-30-14(17)4)15-7-6-8-16(9-15)21(33)25(26,27)28/h6-9,12,21,33H,10-11H2,1-5H3,(H,29,30) XTRMKDQMRVDXNG-UHFFFAOYSA-N 403118 US10329303, Example 14 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403118&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424425 405263093 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805784 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cccc(CO)c3)c2c(=O)n(C)c1=O InChI=1S/C24H28N4O3S/c1-13(2)11-28-23-21(22(30)27(5)24(28)31)20(17-8-6-7-16(9-17)12-29)19(32-23)10-18-14(3)25-26-15(18)4/h6-9,13,29H,10-12H2,1-5H3,(H,25,26) CIZBUZHDLAOFMT-UHFFFAOYSA-N 403142 US10329303, Example 15 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403142&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424364 405263117 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805785 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3ccc(F)c(CO)c3)c2c(=O)n(C2CC2)c1=O InChI=1S/C26H29FN4O3S/c1-13(2)11-30-25-23(24(33)31(26(30)34)18-6-7-18)22(16-5-8-20(27)17(9-16)12-32)21(35-25)10-19-14(3)28-29-15(19)4/h5,8-9,13,18,32H,6-7,10-12H2,1-4H3,(H,28,29) QHJGPRJUXDPBKW-UHFFFAOYSA-N 403155 US10329303, Example 16 Malignant T-cell-amplified sequence 1 220 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403155&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 76401636 405263130 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805786 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cc(C)cc(CO)c3F)c2c(=O)n(C2CC2)c1=O InChI=1S/C27H31FN4O3S/c1-13(2)11-31-26-23(25(34)32(27(31)35)18-6-7-18)22(20-9-14(3)8-17(12-33)24(20)28)21(36-26)10-19-15(4)29-30-16(19)5/h8-9,13,18,33H,6-7,10-12H2,1-5H3,(H,29,30) BJEOKTREPBGOOA-UHFFFAOYSA-N 403158 US10329303, Example 17 Malignant T-cell-amplified sequence 1 100.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403158&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 76401617 405263133 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805787 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cc(F)c(F)c(CO)c3)c2c(=O)n(C2CC2)c1=O InChI=1S/C26H28F2N4O3S/c1-12(2)10-31-25-22(24(34)32(26(31)35)17-5-6-17)21(15-7-16(11-33)23(28)19(27)8-15)20(36-25)9-18-13(3)29-30-14(18)4/h7-8,12,17,33H,5-6,9-11H2,1-4H3,(H,29,30) IJOBUIMRLTUQSB-UHFFFAOYSA-N 403181 US10329303, Example 18 Malignant T-cell-amplified sequence 1 900 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403181&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 76401630 405254692 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805788 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cc(CO)c(F)cc3F)c2c(=O)n(C2CC2)c1=O InChI=1S/C26H28F2N4O3S/c1-12(2)10-31-25-23(24(34)32(26(31)35)16-5-6-16)22(18-7-15(11-33)19(27)9-20(18)28)21(36-25)8-17-13(3)29-30-14(17)4/h7,9,12,16,33H,5-6,8,10-11H2,1-4H3,(H,29,30) ZXVUDYHWDJMBQV-UHFFFAOYSA-N 403182 US10329303, Example 19 Malignant T-cell-amplified sequence 1 70.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403182&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 73438631 405254693 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805789 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cccc(CO)c3F)c2c(=O)n(C2CC2)c1=O InChI=1S/C26H29FN4O3S/c1-13(2)11-30-25-22(24(33)31(26(30)34)17-8-9-17)21(18-7-5-6-16(12-32)23(18)27)20(35-25)10-19-14(3)28-29-15(19)4/h5-7,13,17,32H,8-12H2,1-4H3,(H,28,29) OPYWASXPNJSDRH-UHFFFAOYSA-N 403184 US10329303, Example 20 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403184&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 73438625 405254695 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805790 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3ccc(F)c(CO)c3F)c2c(=O)n(C2CC2)c1=O InChI=1S/C26H28F2N4O3S/c1-12(2)10-31-25-22(24(34)32(26(31)35)15-5-6-15)21(16-7-8-19(27)18(11-33)23(16)28)20(36-25)9-17-13(3)29-30-14(17)4/h7-8,12,15,33H,5-6,9-11H2,1-4H3,(H,29,30) HVBRSJWWPTWSSF-UHFFFAOYSA-N 403188 US10329303, Example 21 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403188&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 73438611 405254699 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805791 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cc(CO)ccc3F)c2c(=O)n(C2CC2)c1=O InChI=1S/C26H29FN4O3S/c1-13(2)11-30-25-23(24(33)31(26(30)34)17-6-7-17)22(19-9-16(12-32)5-8-20(19)27)21(35-25)10-18-14(3)28-29-15(18)4/h5,8-9,13,17,32H,6-7,10-12H2,1-4H3,(H,28,29) CDRKBMSTLFRYKP-UHFFFAOYSA-N 403218 US10329303, Example 22 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403218&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424376 405254729 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805792 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3ccnc(CO)c3)c2c(=O)n(C2CC2)c1=O InChI=1S/C25H29N5O3S/c1-13(2)11-29-24-22(23(32)30(25(29)33)18-5-6-18)21(16-7-8-26-17(9-16)12-31)20(34-24)10-19-14(3)27-28-15(19)4/h7-9,13,18,31H,5-6,10-12H2,1-4H3,(H,27,28) AVTSVTSMJXPVLA-UHFFFAOYSA-N 403224 US10329303, Example 23 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403224&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424361 405254735 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805793 CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cccc(CO)c3)c2c(=O)n(C2CC2)c1=O InChI=1S/C26H30N4O3S/c1-14(2)12-29-25-23(24(32)30(26(29)33)19-8-9-19)22(18-7-5-6-17(10-18)13-31)21(34-25)11-20-15(3)27-28-16(20)4/h5-7,10,14,19,31H,8-9,11-13H2,1-4H3,(H,27,28) LCTBZOZGIJETSJ-UHFFFAOYSA-N 403225 US10329303, Example 24 Malignant T-cell-amplified sequence 1 1.000 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403225&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424387 405254736 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805794 CC(C)Cc1nn(C)c(=O)c2c(-c3ncc(CO)s3)n(Cc3cccc4ccccc34)cc12 InChI=1S/C26H26N4O2S/c1-16(2)11-22-21-14-30(13-18-9-6-8-17-7-4-5-10-20(17)18)24(23(21)26(32)29(3)28-22)25-27-12-19(15-31)33-25/h4-10,12,14,16,31H,11,13,15H2,1-3H3 APVMBADTVFKFHC-UHFFFAOYSA-N 403226 US10329303, Example 25 Malignant T-cell-amplified sequence 1 300 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403226&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424277 405254737 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805795 CC(C)Cc1nn(C)c(=O)c2c(-c3csc(CO)n3)n(Cc3cccc4ccccc34)cc12 InChI=1S/C26H26N4O2S/c1-16(2)11-21-20-13-30(12-18-9-6-8-17-7-4-5-10-19(17)18)25(22-15-33-23(14-31)27-22)24(20)26(32)29(3)28-21/h4-10,13,15-16,31H,11-12,14H2,1-3H3 RQXVTQBVRLDJRU-UHFFFAOYSA-N 403227 US10329303, Example 26 Malignant T-cell-amplified sequence 1 90.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403227&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424284 405254738 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805796 CC(C)Cc1nn(C)c(=O)c2c(-c3ccc(F)c(CO)c3F)n(Cc3cccc4ccccc34)cc12 InChI=1S/C29H27F2N3O2/c1-17(2)13-25-22-15-34(14-19-9-6-8-18-7-4-5-10-20(18)19)28(26(22)29(36)33(3)32-25)21-11-12-24(30)23(16-35)27(21)31/h4-12,15,17,35H,13-14,16H2,1-3H3 VVRINDLTDVAMFF-UHFFFAOYSA-N 403228 US10329303, Example 27 Malignant T-cell-amplified sequence 1 80.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403228&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424339 405254739 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805797 CC(C)Cc1nn(C)c(=O)c2c(-c3cc(CO)ccc3F)n(Cc3cccc4ccccc34)cc12 InChI=1S/C29H28FN3O2/c1-18(2)13-26-24-16-33(15-21-9-6-8-20-7-4-5-10-22(20)21)28(27(24)29(35)32(3)31-26)23-14-19(17-34)11-12-25(23)30/h4-12,14,16,18,34H,13,15,17H2,1-3H3 KEOBEEYUZMGKJN-UHFFFAOYSA-N 403229 US10329303, Example 28 Malignant T-cell-amplified sequence 1 40.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403229&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424229 405254740 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805798 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(CO)c3F)n(Cc3cccc4ccccc34)cc12 InChI=1S/C29H28FN3O2/c1-18(2)14-25-24-16-33(15-20-10-6-9-19-8-4-5-12-22(19)20)28(26(24)29(35)32(3)31-25)23-13-7-11-21(17-34)27(23)30/h4-13,16,18,34H,14-15,17H2,1-3H3 LBUZZXKIDIYWKJ-UHFFFAOYSA-N 403230 US10329303, Example 29 Malignant T-cell-amplified sequence 1 80.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403230&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424410 405254741 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805799 CC(C)Cc1nn(C)c(=O)c2c(-c3cc(CO)ccc3Cl)n(Cc3cccc4ccccc34)cc12 InChI=1S/C29H28ClN3O2/c1-18(2)13-26-24-16-33(15-21-9-6-8-20-7-4-5-10-22(20)21)28(27(24)29(35)32(3)31-26)23-14-19(17-34)11-12-25(23)30/h4-12,14,16,18,34H,13,15,17H2,1-3H3 VVLFYEUQXXXBCB-UHFFFAOYSA-N 403231 US10329303, Example 30 Malignant T-cell-amplified sequence 1 600 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403231&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424345 405254742 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805800 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(CO)c3)n(Cc3cccc4ccccc34)cc12 InChI=1S/C29H29N3O2/c1-19(2)14-26-25-17-32(16-23-12-7-10-21-9-4-5-13-24(21)23)28(27(25)29(34)31(3)30-26)22-11-6-8-20(15-22)18-33/h4-13,15,17,19,33H,14,16,18H2,1-3H3 YIKCNVVTMXFUGO-UHFFFAOYSA-N 403232 US10329303, Example 31 Malignant T-cell-amplified sequence 1 100.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403232&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424395 405254743 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805801 CC(C)Cc1nn(C)c(=O)c2c(-c3cncc(CO)c3)n(Cc3cccc4ccccc34)cc12 InChI=1S/C28H28N4O2/c1-18(2)11-25-24-16-32(15-21-9-6-8-20-7-4-5-10-23(20)21)27(26(24)28(34)31(3)30-25)22-12-19(17-33)13-29-14-22/h4-10,12-14,16,18,33H,11,15,17H2,1-3H3 ZYRFDMJISGNQAU-UHFFFAOYSA-N 403233 US10329303, Example 32 Malignant T-cell-amplified sequence 1 900 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403233&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424224 405254744 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805802 CC(C)Cc1nn(C)c(=O)c2c(-c3csc(c3)C(C)O)n(Cc3cccc4ccccc34)cc12 InChI=1S/C28H29N3O2S/c1-17(2)12-24-23-15-31(14-20-10-7-9-19-8-5-6-11-22(19)20)27(26(23)28(33)30(4)29-24)21-13-25(18(3)32)34-16-21/h5-11,13,15-18,32H,12,14H2,1-4H3 XXJZGVJVXLISJO-UHFFFAOYSA-N 403234 US10329303, Example 33 Malignant T-cell-amplified sequence 1 70.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403234&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424388 405254745 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805803 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(n3)C(C)O)n(Cc3cccc4ccccc34)cc12 InChI=1S/C29H30N4O2/c1-18(2)15-26-23-17-33(16-21-11-7-10-20-9-5-6-12-22(20)21)28(27(23)29(35)32(4)31-26)25-14-8-13-24(30-25)19(3)34/h5-14,17-19,34H,15-16H2,1-4H3 GMKHUKFHRUCUKS-UHFFFAOYSA-N 403235 US10329303, Example 34 Malignant T-cell-amplified sequence 1 1.000 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403235&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424253 405254746 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805804 CC(C)Cc1nn(C)c(=O)c2c(-c3cc(ccc3F)C(C)O)n(Cc3cccc4ccccc34)cc12 InChI=1S/C30H30FN3O2/c1-18(2)14-27-25-17-34(16-22-10-7-9-20-8-5-6-11-23(20)22)29(28(25)30(36)33(4)32-27)24-15-21(19(3)35)12-13-26(24)31/h5-13,15,17-19,35H,14,16H2,1-4H3 CZMUCXWTTRTTNP-UHFFFAOYSA-N 403236 US10329303, Example 35 Malignant T-cell-amplified sequence 1 80.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403236&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424259 405254747 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805805 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(c3)C(C)O)n(Cc3cccc4ccccc34)cc12 InChI=1S/C30H31N3O2/c1-19(2)15-27-26-18-33(17-24-13-7-10-21-9-5-6-14-25(21)24)29(28(26)30(35)32(4)31-27)23-12-8-11-22(16-23)20(3)34/h5-14,16,18-20,34H,15,17H2,1-4H3 TZORKFKCPLBUGB-UHFFFAOYSA-N 403237 US10329303, Example 36 Malignant T-cell-amplified sequence 1 100.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403237&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424386 405254748 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805806 CC(C)Cc1nn(C)c(=O)c2c(-c3csc(n3)C(O)C(F)(F)F)n(Cc3cccc4ccccc34)cc12 InChI=1S/C27H25F3N4O2S/c1-15(2)11-20-19-13-34(12-17-9-6-8-16-7-4-5-10-18(16)17)23(22(19)26(36)33(3)32-20)21-14-37-25(31-21)24(35)27(28,29)30/h4-10,13-15,24,35H,11-12H2,1-3H3 DPCRWRMNMYLGMJ-UHFFFAOYSA-N 403238 US10329303, Example 37 Malignant T-cell-amplified sequence 1 100.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403238&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424200 405254749 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805807 CC(C)Cc1nn(C)c(=O)c2c(-c3csc(c3)C(O)C(F)(F)F)n(Cc3cccc4ccccc34)cc12 InChI=1S/C28H26F3N3O2S/c1-16(2)11-22-21-14-34(13-18-9-6-8-17-7-4-5-10-20(17)18)25(24(21)27(36)33(3)32-22)19-12-23(37-15-19)26(35)28(29,30)31/h4-10,12,14-16,26,35H,11,13H2,1-3H3 DCKXKQKCPWUIPX-UHFFFAOYSA-N 403239 US10329303, Example 38 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403239&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424366 405254750 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805808 CC(C)Cc1nn(C)c(=O)c2c(-c3ccc(s3)C(O)C(F)(F)F)n(Cc3cccc4ccccc34)cc12 InChI=1S/C28H26F3N3O2S/c1-16(2)13-21-20-15-34(14-18-9-6-8-17-7-4-5-10-19(17)18)25(24(20)27(36)33(3)32-21)22-11-12-23(37-22)26(35)28(29,30)31/h4-12,15-16,26,35H,13-14H2,1-3H3 DPJYQYUPNXNSCL-UHFFFAOYSA-N 403240 US10329303, Example 39 Malignant T-cell-amplified sequence 1 90.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403240&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424287 405254751 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805809 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(c3)C(O)C(F)(F)F)n(Cc3cccc4ccccc34)cc12 InChI=1S/C30H28F3N3O2/c1-18(2)14-25-24-17-36(16-22-12-6-9-19-8-4-5-13-23(19)22)27(26(24)29(38)35(3)34-25)20-10-7-11-21(15-20)28(37)30(31,32)33/h4-13,15,17-18,28,37H,14,16H2,1-3H3 BYHCZQHGSWVEEQ-UHFFFAOYSA-N 403241 US10329303, Example 40 Malignant T-cell-amplified sequence 1 50.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403241&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424337 405254752 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805810 CC(C)Cc1nn(C)c(=O)c2c(-c3cc(CO)ccc3F)n(Cc3ccc(cc3)-c3ccccc3)cc12 InChI=1S/C31H30FN3O2/c1-20(2)15-28-26-18-35(17-21-9-12-24(13-10-21)23-7-5-4-6-8-23)30(29(26)31(37)34(3)33-28)25-16-22(19-36)11-14-27(25)32/h4-14,16,18,20,36H,15,17,19H2,1-3H3 ZTMZHRHYRVRAQA-UHFFFAOYSA-N 403242 US10329303, Example 41 Malignant T-cell-amplified sequence 1 800 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403242&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122432427 405254753 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805811 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(c3)C(C)O)n(Cc3ccc(cc3)-c3ccccc3)cc12 InChI=1S/C32H33N3O2/c1-21(2)17-29-28-20-35(19-23-13-15-25(16-14-23)24-9-6-5-7-10-24)31(30(28)32(37)34(4)33-29)27-12-8-11-26(18-27)22(3)36/h5-16,18,20-22,36H,17,19H2,1-4H3 YPJDQOLERRCWNY-UHFFFAOYSA-N 403243 US10329303, Example 42 Malignant T-cell-amplified sequence 1 5500 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403243&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122432428 405254754 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805812 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(CO)c3)n(Cc3c(C)n[nH]c3C)cc12 InChI=1S/C24H29N5O2/c1-14(2)9-21-20-12-29(11-19-15(3)25-26-16(19)4)23(22(20)24(31)28(5)27-21)18-8-6-7-17(10-18)13-30/h6-8,10,12,14,30H,9,11,13H2,1-5H3,(H,25,26) GSRPEGWPUUFWLR-UHFFFAOYSA-N 403244 US10329303, Example 43 Malignant T-cell-amplified sequence 1 500 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403244&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424215 405254755 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805813 CC(C)Cc1nn(C)c(=O)c2c(-c3cc(CO)ccc3F)n(Cc3c(C)n[nH]c3C)cc12 InChI=1S/C24H28FN5O2/c1-13(2)8-21-19-11-30(10-18-14(3)26-27-15(18)4)23(22(19)24(32)29(5)28-21)17-9-16(12-31)6-7-20(17)25/h6-7,9,11,13,31H,8,10,12H2,1-5H3,(H,26,27) LETHMUFOTLCVET-UHFFFAOYSA-N 403245 US10329303, Example 44 Malignant T-cell-amplified sequence 1 200 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403245&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424232 405254756 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805814 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(c3)C(O)C(F)(F)F)n(Cc3c(C)n[nH]c3C)cc12 InChI=1S/C25H28F3N5O2/c1-13(2)9-20-19-12-33(11-18-14(3)29-30-15(18)4)22(21(19)24(35)32(5)31-20)16-7-6-8-17(10-16)23(34)25(26,27)28/h6-8,10,12-13,23,34H,9,11H2,1-5H3,(H,29,30) GJYNLFLVZRKPLK-UHFFFAOYSA-N 403246 US10329303, Example 45 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403246&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424216 405254757 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805815 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(CO)c3)n(Cc3cc(Cl)nc4ccccc34)cc12 InChI=1S/C28H27ClN4O2/c1-17(2)11-24-22-15-33(14-20-13-25(29)30-23-10-5-4-9-21(20)23)27(26(22)28(35)32(3)31-24)19-8-6-7-18(12-19)16-34/h4-10,12-13,15,17,34H,11,14,16H2,1-3H3 RPUVNRIBWQBPSO-UHFFFAOYSA-N 403247 US10329303, Example 46 Malignant T-cell-amplified sequence 1 5500 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403247&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122432419 405254758 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805816 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(CO)c3)n(Cc3cnc(Cl)c4ccccc34)cc12 InChI=1S/C28H27ClN4O2/c1-17(2)11-24-23-15-33(14-20-13-30-27(29)22-10-5-4-9-21(20)22)26(25(23)28(35)32(3)31-24)19-8-6-7-18(12-19)16-34/h4-10,12-13,15,17,34H,11,14,16H2,1-3H3 MASCIEJIJUOZHB-UHFFFAOYSA-N 403248 US10329303, Example 47 Malignant T-cell-amplified sequence 1 5500 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403248&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424309 405254759 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805817 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(CO)c3)n(CCOc3ccccc3Cl)cc12 InChI=1S/C26H28ClN3O3/c1-17(2)13-22-20-15-30(11-12-33-23-10-5-4-9-21(23)27)25(24(20)26(32)29(3)28-22)19-8-6-7-18(14-19)16-31/h4-10,14-15,17,31H,11-13,16H2,1-3H3 ZXMYCLPXADAYIT-UHFFFAOYSA-N 403249 US10329303, Example 48 Malignant T-cell-amplified sequence 1 5500 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403249&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 122424231 405254760 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805818 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(CO)c3)n(Cc3cc(NCN)nc4ccccc34)cc12 InChI=1S/C29H32N6O2/c1-18(2)11-25-23-15-35(14-21-13-26(31-17-30)32-24-10-5-4-9-22(21)24)28(27(23)29(37)34(3)33-25)20-8-6-7-19(12-20)16-36/h4-10,12-13,15,18,36H,11,14,16-17,30H2,1-3H3,(H,31,32) JNPSLMULPBWJJX-UHFFFAOYSA-N 403250 US10329303, Example 49 Malignant T-cell-amplified sequence 1 5500 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403250&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 132270545 405254761 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805819 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(CO)c3)n(Cc3cnc(NCN)c4ccccc34)cc12 InChI=1S/C29H32N6O2/c1-18(2)11-25-24-15-35(14-21-13-31-28(32-17-30)23-10-5-4-9-22(21)23)27(26(24)29(37)34(3)33-25)20-8-6-7-19(12-20)16-36/h4-10,12-13,15,18,36H,11,14,16-17,30H2,1-3H3,(H,31,32) ZPZSILFGTNAZRF-UHFFFAOYSA-N 403251 US10329303, Example 50 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403251&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 132270546 405254762 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805820 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(CO)c3)n(Cc3cc(NCNC(C)=O)nc4ccccc34)cc12 InChI=1S/C31H34N6O3/c1-19(2)12-27-25-16-37(30(29(25)31(40)36(4)35-27)22-9-7-8-21(13-22)17-38)15-23-14-28(33-18-32-20(3)39)34-26-11-6-5-10-24(23)26/h5-11,13-14,16,19,38H,12,15,17-18H2,1-4H3,(H,32,39)(H,33,34) QBCMEMJIWOAPSF-UHFFFAOYSA-N 403252 US10329303, Example 51 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403252&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 132270548 405254763 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 805821 CC(C)Cc1nn(C)c(=O)c2c(-c3cccc(CO)c3)n(Cc3cc(NCNC(=O)C(N)CCC(N)=O)nc4ccccc34)cc12 InChI=1S/C34H40N8O4/c1-20(2)13-28-25-17-42(32(31(25)34(46)41(3)40-28)22-8-6-7-21(14-22)18-43)16-23-15-30(39-27-10-5-4-9-24(23)27)37-19-38-33(45)26(35)11-12-29(36)44/h4-10,14-15,17,20,26,43H,11-13,16,18-19,35H2,1-3H3,(H2,36,44)(H,37,39)(H,38,45) UANXWJKQUVXWSW-UHFFFAOYSA-N 403253 US10329303, Example 52 Malignant T-cell-amplified sequence 1 <20.0 US Patent 10.7270/Q2B27XM9 aid1799360 US10329303 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL The Scripps Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=403253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=403253&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 132270547 405254764 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987420 CC(C)Cn1c2nc(COc3cccc4ccccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C27H32N4O4/c1-18(2)16-31-25-24(26(33)30(3)27(31)34)28-21(13-5-4-8-15-32)22(29-25)17-35-23-14-9-11-19-10-6-7-12-20(19)23/h6-7,9-12,14,18,32H,4-5,8,13,15-17H2,1-3H3 AAEUEFWLAISCKK-UHFFFAOYSA-N 476240 US10874675, Example 2 Malignant T-cell-amplified sequence 1 <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476240&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023136 442076305 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987421 CC(C)Cn1c2nc(COc3cccc4cnccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(9-5-4-6-13-32)21(29-24)16-35-22-10-7-8-18-14-27-12-11-19(18)22/h7-8,10-12,14,17,32H,4-6,9,13,15-16H2,1-3H3 FIHHWLWMXIZNFC-UHFFFAOYSA-N 476241 US10874675, Example 3 Malignant T-cell-amplified sequence 1 <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476241&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023137 442076306 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987422 CC(C)Cn1c2nc(COc3cccc4ncccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(10-5-4-6-14-32)21(29-24)16-35-22-12-7-11-19-18(22)9-8-13-27-19/h7-9,11-13,17,32H,4-6,10,14-16H2,1-3H3 ANJPRASHQRBVNB-UHFFFAOYSA-N 476242 US10874675, Example 4 Malignant T-cell-amplified sequence 1 <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476242&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023138 442076307 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987423 CC(C)Cn1c2nc(COc3cncc4ccccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(11-5-4-8-12-32)21(29-24)16-35-22-14-27-13-18-9-6-7-10-19(18)22/h6-7,9-10,13-14,17,32H,4-5,8,11-12,15-16H2,1-3H3 XGXCZTIKSVRCFZ-UHFFFAOYSA-N 476261 US10874675, Example 5 Malignant T-cell-amplified sequence 1 <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476261&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023151 442076326 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987424 CC(C)Cn1c2nc(COc3cccc4[nH]ccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C25H31N5O4/c1-16(2)14-30-23-22(24(32)29(3)25(30)33)27-19(8-5-4-6-13-31)20(28-23)15-34-21-10-7-9-18-17(21)11-12-26-18/h7,9-12,16,26,31H,4-6,8,13-15H2,1-3H3 ATPOUOURVYPLOY-UHFFFAOYSA-N 476263 US10874675, Example 6 Malignant T-cell-amplified sequence 1 <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476263&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023153 442076328 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987425 CC(C)Cn1c2nc(COc3ccccc3C(F)(F)F)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C24H29F3N4O4/c1-15(2)13-31-21-20(22(33)30(3)23(31)34)28-17(10-5-4-8-12-32)18(29-21)14-35-19-11-7-6-9-16(19)24(25,26)27/h6-7,9,11,15,32H,4-5,8,10,12-14H2,1-3H3 MXAWTNZDOZHUFS-UHFFFAOYSA-N 476264 US10874675, Example 7 Malignant T-cell-amplified sequence 1 <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476264&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023154 442076329 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987426 CC(C)Cn1c2nc(COc3ccc([N+]([O-])=O)c4ccccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C27H31N5O6/c1-17(2)15-31-25-24(26(34)30(3)27(31)35)28-20(11-5-4-8-14-33)21(29-25)16-38-23-13-12-22(32(36)37)18-9-6-7-10-19(18)23/h6-7,9-10,12-13,17,33H,4-5,8,11,14-16H2,1-3H3 SBNSXGFGJNCOJW-UHFFFAOYSA-N 476267 US10874675, Example 8 Malignant T-cell-amplified sequence 1 300 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476267&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023155 442076332 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987427 CC(C)Cn1c2nc(COc3ccc(N)c4ccccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C27H33N5O4/c1-17(2)15-32-25-24(26(34)31(3)27(32)35)29-21(11-5-4-8-14-33)22(30-25)16-36-23-13-12-20(28)18-9-6-7-10-19(18)23/h6-7,9-10,12-13,17,33H,4-5,8,11,14-16,28H2,1-3H3 OVWRROWZIQDOLP-UHFFFAOYSA-N 476268 US10874675, Example 9 Malignant T-cell-amplified sequence 1 <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476268&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023156 442076333 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987428 CC(C)Cn1c2nc(COc3ccc4ccccc4c3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C27H32N4O4/c1-18(2)16-31-25-24(26(33)30(3)27(31)34)28-22(11-5-4-8-14-32)23(29-25)17-35-21-13-12-19-9-6-7-10-20(19)15-21/h6-7,9-10,12-13,15,18,32H,4-5,8,11,14,16-17H2,1-3H3 FVJLJTASWKFQCP-UHFFFAOYSA-N 476269 US10874675, Example 10 Malignant T-cell-amplified sequence 1 <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476269&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023157 442076334 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987429 CC(C)Cn1c2nc(COc3ccccc3Br)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H29BrN4O4/c1-15(2)13-28-21-20(22(30)27(3)23(28)31)25-17(10-5-4-8-12-29)18(26-21)14-32-19-11-7-6-9-16(19)24/h6-7,9,11,15,29H,4-5,8,10,12-14H2,1-3H3 LPTPYXIUNPOMTQ-UHFFFAOYSA-N 476270 US10874675, Example 11 Malignant T-cell-amplified sequence 1 <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476270&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023158 442076335 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987430 CC(C)Cn1c2nc(COc3ccnc4ccccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(11-5-4-8-14-32)21(29-24)16-35-22-12-13-27-19-10-7-6-9-18(19)22/h6-7,9-10,12-13,17,32H,4-5,8,11,14-16H2,1-3H3 BXPOXQVTVAQBFU-UHFFFAOYSA-N 476273 US10874675, Example 12 Malignant T-cell-amplified sequence 1 <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476273&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023159 442076338 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987431 CC(C)Cn1c2nc(COc3ccccc3Cl)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H29ClN4O4/c1-15(2)13-28-21-20(22(30)27(3)23(28)31)25-17(10-5-4-8-12-29)18(26-21)14-32-19-11-7-6-9-16(19)24/h6-7,9,11,15,29H,4-5,8,10,12-14H2,1-3H3 FWUZRGXCRXNFIY-UHFFFAOYSA-N 476274 US10874675, Example 13 Malignant T-cell-amplified sequence 1 <50.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476274&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023160 442076339 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987432 CC(C)Cn1c2nc(COc3ccc(cc3)-c3ccccc3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C29H34N4O4/c1-20(2)18-33-27-26(28(35)32(3)29(33)36)30-24(12-8-5-9-17-34)25(31-27)19-37-23-15-13-22(14-16-23)21-10-6-4-7-11-21/h4,6-7,10-11,13-16,20,34H,5,8-9,12,17-19H2,1-3H3 KNSGAEWYKVZNMJ-UHFFFAOYSA-N 476275 US10874675, Example 14 Malignant T-cell-amplified sequence 1 <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476275&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023161 442076340 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987433 CC(C)Cn1c2nc(COc3ccccc3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H30N4O4/c1-16(2)14-27-21-20(22(29)26(3)23(27)30)24-18(12-8-5-9-13-28)19(25-21)15-31-17-10-6-4-7-11-17/h4,6-7,10-11,16,28H,5,8-9,12-15H2,1-3H3 SXTDEVFFTMXSNN-UHFFFAOYSA-N 476276 US10874675, Example 15 Malignant T-cell-amplified sequence 1 <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476276&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023162 442076341 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987434 CC(C)Cn1c2nc(COc3cccc(c3)C(F)(F)F)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C24H29F3N4O4/c1-15(2)13-31-21-20(22(33)30(3)23(31)34)28-18(10-5-4-6-11-32)19(29-21)14-35-17-9-7-8-16(12-17)24(25,26)27/h7-9,12,15,32H,4-6,10-11,13-14H2,1-3H3 ODXUMEPUIQEVLD-UHFFFAOYSA-N 476277 US10874675, Example 16 Malignant T-cell-amplified sequence 1 <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476277&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023163 442076342 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987435 CC(C)Cn1c2nc(COc3ccccc3F)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H29FN4O4/c1-15(2)13-28-21-20(22(30)27(3)23(28)31)25-17(10-5-4-8-12-29)18(26-21)14-32-19-11-7-6-9-16(19)24/h6-7,9,11,15,29H,4-5,8,10,12-14H2,1-3H3 RHNMPKYXTDYQDX-UHFFFAOYSA-N 476278 US10874675, Example 17 Malignant T-cell-amplified sequence 1 <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476278&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023164 442076343 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987436 CC(C)Cn1c2nc(COc3ccc4ncccc4c3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-21(9-5-4-6-13-32)22(29-24)16-35-19-10-11-20-18(14-19)8-7-12-27-20/h7-8,10-12,14,17,32H,4-6,9,13,15-16H2,1-3H3 ZRYWWBDGYKHMDR-UHFFFAOYSA-N 476279 US10874675, Example 18 Malignant T-cell-amplified sequence 1 <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476279&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023165 442076344 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987437 CC(C)Cn1c2nc(COc3ccc(Br)cc3Br)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H28Br2N4O4/c1-14(2)12-29-21-20(22(31)28(3)23(29)32)26-17(7-5-4-6-10-30)18(27-21)13-33-19-9-8-15(24)11-16(19)25/h8-9,11,14,30H,4-7,10,12-13H2,1-3H3 QOVJUWJBUQJFHU-UHFFFAOYSA-N 476280 US10874675, Example 19 Malignant T-cell-amplified sequence 1 <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476280&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023166 442076345 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987438 CC(C)Cn1c2nc(COc3ccc4cccnc4c3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(9-5-4-6-13-32)22(29-24)16-35-19-11-10-18-8-7-12-27-21(18)14-19/h7-8,10-12,14,17,32H,4-6,9,13,15-16H2,1-3H3 ZRPCCABJMGSWMP-UHFFFAOYSA-N 476281 US10874675, Example 20 Malignant T-cell-amplified sequence 1 <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476281&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023167 442076346 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987439 CC(C)Cn1c2nc(COc3ccc(Cl)cc3Br)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H28BrClN4O4/c1-14(2)12-29-21-20(22(31)28(3)23(29)32)26-17(7-5-4-6-10-30)18(27-21)13-33-19-9-8-15(25)11-16(19)24/h8-9,11,14,30H,4-7,10,12-13H2,1-3H3 ASPDTOYZUQEARO-UHFFFAOYSA-N 476282 US10874675, Example 21 Malignant T-cell-amplified sequence 1 <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476282&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023168 442076347 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987440 CC(C)Cn1c2nc(COc3ccc(cc3)C(F)(F)F)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C24H29F3N4O4/c1-15(2)13-31-21-20(22(33)30(3)23(31)34)28-18(7-5-4-6-12-32)19(29-21)14-35-17-10-8-16(9-11-17)24(25,26)27/h8-11,15,32H,4-7,12-14H2,1-3H3 CYCYPUYYTORBNO-UHFFFAOYSA-N 476283 US10874675, Example 22 Malignant T-cell-amplified sequence 1 <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476283&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023169 442076348 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987441 CC(C)Cn1c2nc(COc3ccccc3-c3ccccc3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C29H34N4O4/c1-20(2)18-33-27-26(28(35)32(3)29(33)36)30-23(15-8-5-11-17-34)24(31-27)19-37-25-16-10-9-14-22(25)21-12-6-4-7-13-21/h4,6-7,9-10,12-14,16,20,34H,5,8,11,15,17-19H2,1-3H3 WFZKCIKHDPKHGE-UHFFFAOYSA-N 476284 US10874675, Example 23 Malignant T-cell-amplified sequence 1 <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476284&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023170 442076349 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987442 CC(C)Cn1c2nc(COc3cc(F)ccc3Br)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H28BrFN4O4/c1-14(2)12-29-21-20(22(31)28(3)23(29)32)26-17(7-5-4-6-10-30)18(27-21)13-33-19-11-15(25)8-9-16(19)24/h8-9,11,14,30H,4-7,10,12-13H2,1-3H3 QPKWOVDQVFXBOF-UHFFFAOYSA-N 476285 US10874675, Example 24 Malignant T-cell-amplified sequence 1 <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476285&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023171 442076350 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987443 CC(C)Cn1c2nc(COc3cccc4ccncc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(9-5-4-6-13-32)21(29-24)16-35-22-10-7-8-18-11-12-27-14-19(18)22/h7-8,10-12,14,17,32H,4-6,9,13,15-16H2,1-3H3 XQJJRNLAIMJUDO-UHFFFAOYSA-N 476287 US10874675, Example 25 Malignant T-cell-amplified sequence 1 <250 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476287&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023172 442076352 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987444 CC(C)Cn1c2nc(COc3cccc4cccnc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-19(11-5-4-6-14-32)20(29-24)16-35-21-12-7-9-18-10-8-13-27-22(18)21/h7-10,12-13,17,32H,4-6,11,14-16H2,1-3H3 KIFPNZPBSRAVOS-UHFFFAOYSA-N 476288 US10874675, Example 26 Malignant T-cell-amplified sequence 1 <500 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476288&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023173 442076353 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987445 CC(C)Cn1c2nc(COc3cc4ccccc4cn3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H31N5O4/c1-17(2)15-31-24-23(25(33)30(3)26(31)34)28-20(11-5-4-8-12-32)21(29-24)16-35-22-13-18-9-6-7-10-19(18)14-27-22/h6-7,9-10,13-14,17,32H,4-5,8,11-12,15-16H2,1-3H3 KRVCNHKXUWJLIH-UHFFFAOYSA-N 476289 US10874675, Example 27 Malignant T-cell-amplified sequence 1 <500 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476289&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023174 442076354 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987446 CC(C)Cn1c2nc(COc3ccncc3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C22H29N5O4/c1-15(2)13-27-20-19(21(29)26(3)22(27)30)24-17(7-5-4-6-12-28)18(25-20)14-31-16-8-10-23-11-9-16/h8-11,15,28H,4-7,12-14H2,1-3H3 HBUPYJWADTUVBN-UHFFFAOYSA-N 476291 US10874675, Example 28 Malignant T-cell-amplified sequence 1 <1000 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476291&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023175 442076356 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987447 CC(C)Cn1c2nc(COc3c(Br)cc(Br)c4cnccc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C26H29Br2N5O4/c1-15(2)13-33-24-22(25(35)32(3)26(33)36)30-20(7-5-4-6-10-34)21(31-24)14-37-23-16-8-9-29-12-17(16)18(27)11-19(23)28/h8-9,11-12,15,34H,4-7,10,13-14H2,1-3H3 JELIXQBORFHDGB-UHFFFAOYSA-N 476292 US10874675, Example 29 Malignant T-cell-amplified sequence 1 <1000 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476292&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023176 442076357 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987448 CC(C)Cn1c2nc(COc3cccc4nccnc34)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C25H30N6O4/c1-16(2)14-31-23-22(24(33)30(3)25(31)34)28-17(8-5-4-6-13-32)19(29-23)15-35-20-10-7-9-18-21(20)27-12-11-26-18/h7,9-12,16,32H,4-6,8,13-15H2,1-3H3 CKSQCCNLTRMURI-UHFFFAOYSA-N 476293 US10874675, Example 30 Malignant T-cell-amplified sequence 1 <1000 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476293&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023177 442076358 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987449 CC(C)Cn1c2nc(COc3cccnc3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C22H29N5O4/c1-15(2)13-27-20-19(21(29)26(3)22(27)30)24-17(9-5-4-6-11-28)18(25-20)14-31-16-8-7-10-23-12-16/h7-8,10,12,15,28H,4-6,9,11,13-14H2,1-3H3 ITABJFLADVHYOL-UHFFFAOYSA-N 476294 US10874675, Example 31 Malignant T-cell-amplified sequence 1 <1000 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476294&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023178 442076359 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987450 CC(C)Cn1c2nc(COc3cccc(c3)[N+]([O-])=O)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H29N5O6/c1-15(2)13-27-21-20(22(30)26(3)23(27)31)24-18(10-5-4-6-11-29)19(25-21)14-34-17-9-7-8-16(12-17)28(32)33/h7-9,12,15,29H,4-6,10-11,13-14H2,1-3H3 NNORJQDWLVFEMM-UHFFFAOYSA-N 476295 US10874675, Example 32 Malignant T-cell-amplified sequence 1 <1000 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476295&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023179 442076360 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987451 CC(C)Cn1c2nc(COc3cccc(N)c3)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C23H31N5O4/c1-15(2)13-28-21-20(22(30)27(3)23(28)31)25-18(10-5-4-6-11-29)19(26-21)14-32-17-9-7-8-16(24)12-17/h7-9,12,15,29H,4-6,10-11,13-14,24H2,1-3H3 TUDNASVHEPSHJY-UHFFFAOYSA-N 476296 US10874675, Example 33 Malignant T-cell-amplified sequence 1 <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476296&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023180 442076361 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987452 CC(C)Cn1c2nc(COc3ccccc3C#N)c(CCCCCO)nc2c(=O)n(C)c1=O InChI=1S/C24H29N5O4/c1-16(2)14-29-22-21(23(31)28(3)24(29)32)26-18(10-5-4-8-12-30)19(27-22)15-33-20-11-7-6-9-17(20)13-25/h6-7,9,11,16,30H,4-5,8,10,12,14-15H2,1-3H3 GSFWRWWJMRBIBH-UHFFFAOYSA-N 476297 US10874675, Example 34 Malignant T-cell-amplified sequence 1 >2000 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476297&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023181 442076362 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6 987453 CC(C)Cn1c2nc(COc3cccc4ccccc34)c(CCc3ccccc3CO)nc2c(=O)n(C)c1=O InChI=1S/C31H32N4O4/c1-20(2)17-35-29-28(30(37)34(3)31(35)38)32-25(16-15-21-9-4-5-11-23(21)18-36)26(33-29)19-39-27-14-8-12-22-10-6-7-13-24(22)27/h4-14,20,36H,15-19H2,1-3H3 PFFZKXJCCFVGQG-UHFFFAOYSA-N 476298 US10874675, Example 35 Malignant T-cell-amplified sequence 1 <100.0 US Patent 10.7270/Q29W0JJ5 aid1805112 US10874675 Bannister, TD; Wang, H; Wang, C; Cleveland, JL THE SCRIPPS RESEARCH INSTITUTE http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=594&target=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476298&enzyme=Malignant+T-cell-amplified+sequence+1&column=ki&startPg=0&Increment=50&submit=Search 156023182 442076363 1 MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK 5ONS,6MS4 Malignant T-cell-amplified sequence 1 MCTS1_HUMAN Q9ULC4 B4DGY2 Q502X6